subject: PR:000001026

object_name: Stage IB Ovarian Cancer AJCC v8


subject: PR:000001026

subject_name: lymphocyte antigen 75

object_name: Stage IA Ovarian Cancer AJCC v8

tested_intervention: unsure


subject: PR:000001026

object_name: Stage IA Ovarian Cancer


subject: PR:000001026

object_name: Stage IB Uterine Corpus Cancer AJCC v7


subject: PR:000001026

object_name: Stage II Uterine Corpus Cancer


subject: PR:000001026

object_name: Stage IA Uterine Corpus Cancer AJCC v7


subject: PR:000001026

object_name: Stage IVB Uterine Corpus Cancer AJCC v7


subject: PR:000001026

object_name: Stage IVA Uterine Corpus Cancer AJCC v7


subject: PR:000001026

object_name: Stage IIIA Uterine Corpus Cancer AJCC v7


subject: PR:000001026

object_name: Stage IIIB Uterine Corpus Cancer AJCC v7


subject: PR:000001026

object_name: Stage IIIC Uterine Corpus Cancer AJCC v7


subject: PR:000001026

object_name: Stage IIA Ovarian Cancer AJCC v8


subject: PR:000001026

object_name: Stage IIA Ovarian Cancer AJCC V6 and v7


subject: PR:000001026

object_name: Stage IIIB Breast Carcinoma


subject: PR:000001026

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: PR:000001026

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: PR:000001026

object_name: Stage IIB Ovarian Cancer AJCC v6 and v7


subject: PR:000001026

object_name: Stage IIB Ovarian Cancer AJCC v8


subject: PR:000001026

object_name: Stage IIC Ovarian Cancer AJCC v6 and v7


subject: PR:000001026

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: PR:000001026

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: PR:000001026

object_name: Stage IIIA Breast Carcinoma


subject: PR:000001026

object_name: Stage IIIC Breast Cancer AJCC v6


subject: PR:000001026

object_name: Stage IIIC Breast Cancer AJCC v7


subject: PR:000001026

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: PR:000001026

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: PR:000001026

object_name: Stage IIIA Ovarian Cancer AJCC v6 and v7


subject: PR:000001026

object_name: Stage IIIA Ovarian Cancer AJCC v8


subject: PR:000001026

object_name: Stage IIIB Ovarian Cancer AJCC v6 and v7


subject: PR:000001026

object_name: Stage IIIB Ovarian Cancer AJCC v8


subject: PR:000001026

object_name: Stage IIIC Ovarian Cancer AJCC v8


subject: PR:000001026

object_name: Stage IIIC Ovarian Cancer


subject: PR:000001026

object_name: Stage IV Esophageal Cancer AJCC v6


subject: PR:000001026

object_name: Stage IV Esophageal Cancer AJCC v7


subject: PR:000001026

object_name: stage IV esophageal cancer


subject: PR:000001026

object_name: Stage IIB Esophageal Carcinoma


subject: PR:000001026

object_name: stage IIIB esophageal cancer


subject: PR:000001026

object_name: Stage IIIB Esophageal Cancer AJCC v7


subject: PR:000001026

object_name: Stage IIIA Esophageal Cancer AJCC v7


subject: PR:000001026

object_name: stage IIIA esophageal cancer


subject: PR:000001026

object_name: stage IIIC esophageal cancer


subject: PR:000001026

object_name: Stage IIIC Esophageal Cancer AJCC v7


subject: PR:000001026

object_name: Renal cell carcinoma recurrent


subject: PR:000001026

object_name: Estrogen Receptor Positive


subject: PR:000001026

object_name: Recurrent Hepatocellular Carcinoma


subject: PR:000001026

object_name: Prostate cancer recurrent


subject: PR:000001026

object_name: Colorectal cancer recurrent


subject: PR:000001026

object_name: Bladder transitional cell carcinoma stage IV


subject: PR:000001026

object_name: Estrogen Receptor Negative


subject: PR:000001026

object_name: Childhood Anaplastic Oligodendroglioma


subject: PR:000001026

object_name: anaplastic oligodendroglioma


subject: PR:000001026

object_name: Adult Anaplastic Oligodendroglioma


subject: PR:000001026

object_name: recurrent gastric cancer


subject: PR:000001026

object_name: Carcinoma liver resectable


subject: PR:000001026

object_name: metastatic prostate carcinoma


subject: PR:000001026

object_name: Oesophageal carcinoma recurrent


subject: PR:000001026

object_name: Recurrent Adult Brain Neoplasm


subject: PR:000001026

object_name: Recurrent ovarian cancer


subject: PR:000001026

object_name: Bladder cancer recurrent


subject: PR:000001026

object_name: Breast cancer recurrent


subject: PR:000001026

object_name: Childhood Anaplastic Oligoastrocytoma


subject: PR:000001026

object_name: anaplastic oligoastrocytoma


subject: PR:000001026

object_name: Recurrent Unspecified Lung Carcinoma


subject: PR:000001026

object_name: Grade III Childhood Astrocytoma


subject: PR:000001026

object_name: Adult Anaplastic Astrocytoma


subject: PR:000001026

object_name: anaplastic astrocytoma


subject: PR:000001026

object_name: Melanoma recurrent


subject: PR:000001026

object_name: Stage IIIA Lung Cancer AJCC v7


subject: PR:000001026

object_name: stage IIIB melanoma


subject: PR:000001026

object_name: stage IIIC melanoma


subject: PR:000001026

object_name: Stage IIA Lung Cancer AJCC v7


subject: PR:000001026

object_name: Stage IIB Lung Cancer AJCC v7


subject: PR:000001026

object_name: stage IIIA melanoma


subject: PR:000001026

object_name: stage IIC melanoma


subject: PR:000001026

object_name: Stage IIC Cutaneous Melanoma AJCC v6 and v7


subject: PR:000001026

object_name: stage IIB melanoma


subject: PR:000001026

object_name: glioblastoma


subject: PR:000001026

object_name: Childhood Glioblastoma


subject: PR:000001026

object_name: adult glioblastoma


subject: PR:000001026

object_name: malignant soft tissue neoplasm


subject: PR:000001026

object_name: sarcoma


subject: UniProtKB:O60449

object_name: Metastatic Renal Cell Carcinoma


subject: UniProtKB:O60449

object_name: Metastatic Renal Cell Cancer


subject: UniProtKB:O60449

object_name: Stage IV Prostate Cancer AJCC v6


subject: UniProtKB:O60449

object_name: Carcinoma of the prostate stage IV


subject: UniProtKB:O60449

object_name: Stage IV Prostate Cancer AJCC v7


subject: UniProtKB:O60449

object_name: Stage IV Prostate Cancer AJCC v8


subject: UniProtKB:O60449

object_name: hormone-resistant prostate carcinoma


subject: UniProtKB:O60449

object_name: Anatomic Stage IA Breast Cancer AJCC v8


subject: UniProtKB:O60449

object_name: Prognostic Stage IA Breast Cancer AJCC v8


subject: UniProtKB:O60449

object_name: Stage IA Breast Cancer AJCC v7


subject: UniProtKB:O60449

object_name: stage IA breast cancer


subject: UniProtKB:O60449

object_name: Anatomic Stage IB Breast Cancer AJCC v8


subject: UniProtKB:O60449

object_name: Prognostic Stage IB Breast Cancer AJCC v8


subject: UniProtKB:O60449

object_name: Stage IB Breast Cancer AJCC v7


subject: UniProtKB:O60449

object_name: Prognostic Stage IIA Breast Cancer AJCC v8


subject: UniProtKB:O60449

object_name: Anatomic Stage IIA Breast Cancer AJCC v8


subject: UniProtKB:O60449

object_name: Stage IIA Breast Carcinoma


subject: UniProtKB:O60449

object_name: Stage IC Ovarian Cancer AJCC v6 and v7


subject: UniProtKB:O60449

object_name: Stage IC Ovarian Cancer AJCC v8


subject: UniProtKB:O60449

object_name: Stage IV Ovarian Cancer AJCC v6 and v7


subject: UniProtKB:O60449

object_name: Stage IV Ovarian Cancer AJCC v8


subject: UniProtKB:O60449

object_name: Ovarian cancer stage IV


subject: UniProtKB:O60449

object_name: Anatomic Stage IIB Breast Cancer AJCC v8


subject: UniProtKB:O60449

object_name: Prognostic Stage IIB Breast Cancer AJCC v8


subject: UniProtKB:O60449

object_name: Stage IIB Breast Carcinoma


subject: UniProtKB:O60449

object_name: malignant neoplasm of breast stage IIb


subject: UniProtKB:O60449

object_name: Stage IB Ovarian Cancer AJCC v6 and v7


subject: UniProtKB:O60449

object_name: Stage IB Ovarian Cancer AJCC v8


subject: UniProtKB:O60449

object_name: Stage IA Ovarian Cancer AJCC v8


subject: UniProtKB:O60449

object_name: Stage IA Ovarian Cancer


subject: UniProtKB:O60449

object_name: Stage IB Uterine Corpus Cancer AJCC v7


subject: UniProtKB:O60449

object_name: Stage II Uterine Corpus Cancer


subject: UniProtKB:O60449

object_name: Stage IA Uterine Corpus Cancer AJCC v7


subject: UniProtKB:O60449

object_name: Stage IVB Uterine Corpus Cancer AJCC v7


subject: UniProtKB:O60449

object_name: Stage IVA Uterine Corpus Cancer AJCC v7


subject: UniProtKB:O60449

object_name: Stage IIIA Uterine Corpus Cancer AJCC v7


subject: UniProtKB:O60449

object_name: Stage IIIB Uterine Corpus Cancer AJCC v7


subject: UniProtKB:O60449

object_name: Stage IIIC Uterine Corpus Cancer AJCC v7


subject: UniProtKB:O60449

object_name: Stage IIA Ovarian Cancer AJCC v8


subject: UniProtKB:O60449

object_name: Stage IIA Ovarian Cancer AJCC V6 and v7


subject: UniProtKB:O60449

object_name: Stage IIIB Breast Carcinoma


subject: UniProtKB:O60449

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: UniProtKB:O60449

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: UniProtKB:O60449

object_name: Stage IIB Ovarian Cancer AJCC v6 and v7


subject: UniProtKB:O60449

object_name: Stage IIB Ovarian Cancer AJCC v8


subject: UniProtKB:O60449

object_name: Stage IIC Ovarian Cancer AJCC v6 and v7


subject: UniProtKB:O60449

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: UniProtKB:O60449

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: UniProtKB:O60449

object_name: Stage IIIA Breast Carcinoma


subject: UniProtKB:O60449

object_name: Stage IIIC Breast Cancer AJCC v6


subject: UniProtKB:O60449

object_name: Stage IIIC Breast Cancer AJCC v7


subject: UniProtKB:O60449

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: UniProtKB:O60449

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: UniProtKB:O60449

object_name: Stage IIIA Ovarian Cancer AJCC v6 and v7


subject: UniProtKB:O60449

object_name: Stage IIIA Ovarian Cancer AJCC v8


subject: UniProtKB:O60449

object_name: Stage IIIB Ovarian Cancer AJCC v6 and v7


subject: UniProtKB:O60449

object_name: Stage IIIB Ovarian Cancer AJCC v8


subject: UniProtKB:O60449

object_name: Stage IIIC Ovarian Cancer AJCC v8


subject: UniProtKB:O60449

object_name: Stage IIIC Ovarian Cancer


subject: UniProtKB:O60449

object_name: Stage IV Esophageal Cancer AJCC v6


subject: UniProtKB:O60449

object_name: Stage IV Esophageal Cancer AJCC v7


subject: UniProtKB:O60449

object_name: stage IV esophageal cancer


subject: UniProtKB:O60449

object_name: Stage IIB Esophageal Carcinoma


subject: UniProtKB:O60449

object_name: stage IIIB esophageal cancer


subject: UniProtKB:O60449

object_name: Stage IIIB Esophageal Cancer AJCC v7


subject: UniProtKB:O60449

object_name: Stage IIIA Esophageal Cancer AJCC v7


subject: UniProtKB:O60449

object_name: stage IIIA esophageal cancer


subject: UniProtKB:O60449

object_name: stage IIIC esophageal cancer


subject: UniProtKB:O60449

object_name: Stage IIIC Esophageal Cancer AJCC v7


subject: UniProtKB:O60449

object_name: Renal cell carcinoma recurrent


subject: UniProtKB:O60449

object_name: Estrogen Receptor Positive


subject: UniProtKB:O60449

object_name: Recurrent Hepatocellular Carcinoma


subject: UniProtKB:O60449

object_name: Prostate cancer recurrent


subject: UniProtKB:O60449

object_name: Colorectal cancer recurrent


subject: UniProtKB:O60449

object_name: Bladder transitional cell carcinoma stage IV


subject: UniProtKB:O60449

object_name: Estrogen Receptor Negative


subject: UniProtKB:O60449

object_name: Childhood Anaplastic Oligodendroglioma


subject: UniProtKB:O60449

object_name: anaplastic oligodendroglioma


subject: UniProtKB:O60449

object_name: Adult Anaplastic Oligodendroglioma


subject: UniProtKB:O60449

object_name: recurrent gastric cancer


subject: UniProtKB:O60449

object_name: Carcinoma liver resectable


subject: UniProtKB:O60449

object_name: metastatic prostate carcinoma


subject: UniProtKB:O60449

object_name: Oesophageal carcinoma recurrent


subject: UniProtKB:O60449

object_name: Recurrent Adult Brain Neoplasm


subject: UniProtKB:O60449

object_name: Recurrent ovarian cancer


subject: UniProtKB:O60449

object_name: Bladder cancer recurrent


subject: UniProtKB:O60449

object_name: Breast cancer recurrent


subject: UniProtKB:O60449

object_name: Childhood Anaplastic Oligoastrocytoma


subject: UniProtKB:O60449

object_name: anaplastic oligoastrocytoma


subject: UniProtKB:O60449

object_name: Recurrent Unspecified Lung Carcinoma


subject: UniProtKB:O60449

object_name: Grade III Childhood Astrocytoma


subject: UniProtKB:O60449

object_name: Adult Anaplastic Astrocytoma


subject: UniProtKB:O60449

object_name: anaplastic astrocytoma


subject: UniProtKB:O60449

object_name: Melanoma recurrent


subject: UniProtKB:O60449

object_name: Stage IIIA Lung Cancer AJCC v7


subject: UniProtKB:O60449

object_name: stage IIIB melanoma


subject: UniProtKB:O60449

object_name: stage IIIC melanoma


subject: UniProtKB:O60449

object_name: Stage IIA Lung Cancer AJCC v7


subject: UniProtKB:O60449

object_name: Stage IIB Lung Cancer AJCC v7


subject: UniProtKB:O60449

object_name: stage IIIA melanoma


subject: UniProtKB:O60449

object_name: stage IIC melanoma


subject: UniProtKB:O60449

object_name: Stage IIC Cutaneous Melanoma AJCC v6 and v7


subject: UniProtKB:O60449

object_name: stage IIB melanoma


subject: UniProtKB:O60449

object_name: glioblastoma


subject: UniProtKB:O60449

object_name: Childhood Glioblastoma


subject: UniProtKB:O60449

object_name: adult glioblastoma


subject: UniProtKB:O60449

object_name: malignant soft tissue neoplasm


subject: UniProtKB:O60449

object_name: sarcoma


subject: CHEBI:9168

subject_name: Sirolimus

object_name: Metastatic Renal Cell Carcinoma


subject: CHEBI:9168

object_name: Metastatic Renal Cell Cancer


subject: CHEBI:9168

object_name: Stage IV Prostate Cancer AJCC v6


subject: CHEBI:9168

object_name: Carcinoma of the prostate stage IV


subject: CHEBI:9168

object_name: Stage IV Prostate Cancer AJCC v7


subject: CHEBI:9168

object_name: Stage IV Prostate Cancer AJCC v8


subject: CHEBI:9168

object_name: hormone-resistant prostate carcinoma


subject: CHEBI:9168

object_name: Anatomic Stage IA Breast Cancer AJCC v8


subject: CHEBI:9168

object_name: Prognostic Stage IA Breast Cancer AJCC v8


subject: CHEBI:9168

object_name: Stage IA Breast Cancer AJCC v7


subject: CHEBI:9168

object_name: stage IA breast cancer


subject: CHEBI:9168

object_name: Anatomic Stage IB Breast Cancer AJCC v8


subject: CHEBI:9168

object_name: Prognostic Stage IB Breast Cancer AJCC v8


subject: CHEBI:9168

object_name: Stage IB Breast Cancer AJCC v7


subject: CHEBI:9168

object_name: Prognostic Stage IIA Breast Cancer AJCC v8


subject: CHEBI:9168

object_name: Anatomic Stage IIA Breast Cancer AJCC v8


subject: CHEBI:9168

object_name: Stage IIA Breast Carcinoma


subject: CHEBI:9168

object_name: Stage IC Ovarian Cancer AJCC v6 and v7


subject: CHEBI:9168

object_name: Stage IC Ovarian Cancer AJCC v8


subject: CHEBI:9168

object_name: Stage IV Ovarian Cancer AJCC v8

tested_intervention: yes


subject: CHEBI:9168

object_name: Anatomic Stage IIB Breast Cancer AJCC v8


subject: CHEBI:9168

object_name: Prognostic Stage IIB Breast Cancer AJCC v8


subject: CHEBI:9168

object_name: Stage IIB Breast Carcinoma


subject: CHEBI:9168

object_name: malignant neoplasm of breast stage IIb


subject: CHEBI:9168

object_name: Stage IB Ovarian Cancer AJCC v6 and v7


subject: CHEBI:9168

object_name: Stage IB Ovarian Cancer AJCC v8


subject: CHEBI:9168

object_name: Stage IA Ovarian Cancer AJCC v8


subject: CHEBI:9168

object_name: Stage IA Ovarian Cancer


subject: CHEBI:9168

object_name: Stage IB Uterine Corpus Cancer AJCC v7


subject: CHEBI:9168

object_name: Stage II Uterine Corpus Cancer


subject: CHEBI:9168

object_name: Stage IA Uterine Corpus Cancer AJCC v7


subject: CHEBI:9168

object_name: Stage IVB Uterine Corpus Cancer AJCC v7


subject: CHEBI:9168

object_name: Stage IVA Uterine Corpus Cancer AJCC v7


subject: CHEBI:9168

object_name: Stage IIIA Uterine Corpus Cancer AJCC v7


subject: CHEBI:9168

object_name: Stage IIIB Uterine Corpus Cancer AJCC v7


subject: CHEBI:9168

object_name: Stage IIIC Uterine Corpus Cancer AJCC v7


subject: CHEBI:9168

object_name: Stage IIA Ovarian Cancer AJCC v8


subject: CHEBI:9168

object_name: Stage IIIB Breast Carcinoma


subject: CHEBI:9168

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:9168

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:9168

object_name: Stage IIB Ovarian Cancer AJCC v8


subject: CHEBI:9168

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:9168

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:9168

object_name: Stage IIIA Breast Carcinoma


subject: CHEBI:9168

object_name: Stage IIIC Breast Cancer AJCC v6


subject: CHEBI:9168

object_name: Stage IIIC Breast Cancer AJCC v7


subject: CHEBI:9168

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:9168

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:9168

object_name: Stage IIIA Ovarian Cancer AJCC v8


subject: CHEBI:9168

object_name: Stage IIIB Ovarian Cancer AJCC v8


subject: CHEBI:9168

object_name: Stage IIIC Ovarian Cancer AJCC v8


subject: CHEBI:9168

object_name: Stage IV Esophageal Cancer AJCC v6


subject: CHEBI:9168

object_name: Stage IV Esophageal Cancer AJCC v7


subject: CHEBI:9168

object_name: stage IV esophageal cancer


subject: CHEBI:9168

object_name: Stage IIB Esophageal Carcinoma


subject: CHEBI:9168

object_name: stage IIIB esophageal cancer


subject: CHEBI:9168

object_name: Stage IIIB Esophageal Cancer AJCC v7


subject: CHEBI:9168

object_name: Stage IIIA Esophageal Cancer AJCC v7


subject: CHEBI:9168

object_name: stage IIIA esophageal cancer


subject: CHEBI:9168

object_name: stage IIIC esophageal cancer


subject: CHEBI:9168

object_name: Stage IIIC Esophageal Cancer AJCC v7


subject: CHEBI:9168

object_name: Renal cell carcinoma recurrent


subject: CHEBI:9168

object_name: Estrogen Receptor Positive


subject: CHEBI:9168

object_name: Recurrent Hepatocellular Carcinoma


subject: CHEBI:9168

object_name: Prostate cancer recurrent


subject: CHEBI:9168

object_name: Colorectal cancer recurrent


subject: CHEBI:9168

object_name: Bladder transitional cell carcinoma stage IV


subject: CHEBI:9168

object_name: Estrogen Receptor Negative


subject: CHEBI:9168

object_name: Childhood Anaplastic Oligodendroglioma


subject: CHEBI:9168

object_name: anaplastic oligodendroglioma


subject: CHEBI:9168

object_name: Adult Anaplastic Oligodendroglioma


subject: CHEBI:9168

object_name: recurrent gastric cancer


subject: CHEBI:9168

object_name: Carcinoma liver resectable


subject: CHEBI:9168

object_name: metastatic prostate carcinoma


subject: CHEBI:9168

object_name: Oesophageal carcinoma recurrent


subject: CHEBI:9168

object_name: Recurrent Adult Brain Neoplasm


subject: CHEBI:9168

object_name: Bladder cancer recurrent


subject: CHEBI:9168

object_name: Breast cancer recurrent


subject: CHEBI:9168

object_name: Childhood Anaplastic Oligoastrocytoma


subject: CHEBI:9168

object_name: anaplastic oligoastrocytoma


subject: CHEBI:9168

object_name: Recurrent Unspecified Lung Carcinoma


subject: CHEBI:9168

object_name: Grade III Childhood Astrocytoma


subject: CHEBI:9168

object_name: Adult Anaplastic Astrocytoma


subject: CHEBI:9168

object_name: anaplastic astrocytoma


subject: CHEBI:9168

object_name: Melanoma recurrent


subject: CHEBI:9168

object_name: Stage IIIA Lung Cancer AJCC v7


subject: CHEBI:9168

object_name: stage IIIB melanoma


subject: CHEBI:9168

object_name: stage IIIC melanoma


subject: CHEBI:9168

object_name: Stage IIA Lung Cancer AJCC v7


subject: CHEBI:9168

object_name: Stage IIB Lung Cancer AJCC v7


subject: CHEBI:9168

object_name: stage IIIA melanoma


subject: CHEBI:9168

object_name: stage IIC melanoma


subject: CHEBI:9168

object_name: Stage IIC Cutaneous Melanoma AJCC v6 and v7


subject: CHEBI:9168

object_name: stage IIB melanoma


subject: CHEBI:9168

object_name: glioblastoma


subject: CHEBI:9168

object_name: Childhood Glioblastoma


subject: CHEBI:9168

object_name: adult glioblastoma


subject: UMLS:C5555836

subject_name: Fluorine F 18 Fluoropivalate

object_name: Childhood Solid Neoplasm


subject: UMLS:C5555836

object_name: Adult Solid Neoplasm


subject: UMLS:C5555836

object_name: Solid Neoplasm


subject: UMLS:C5555836

object_name: cancer


subject: UMLS:C5555836

object_name: neoplasm


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: transient congenital hypothyroidism


subject: UMLS:C3819106

subject_name: Pedia-Lax Probiotic

object_name: digestive system infectious disorder


subject: UMLS:C3819106

object_name: Infantile Colic


subject: UMLS:C3819106

object_name: Abdominal colic


subject: CHEBI:201431

subject_name: Cyclosporin H

object_name: mature T-cell and NK-cell non-Hodgkin lymphoma


subject: CHEBI:201431

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: CHEBI:201431

object_name: DS Stage II Plasma Cell Myeloma


subject: CHEBI:201431

object_name: ISS Stage II Plasma Cell Myeloma


subject: CHEBI:201431

object_name: primary cutaneous B-cell lymphoma


subject: CHEBI:201431

object_name: ISS Stage III Plasma Cell Myeloma


subject: CHEBI:201431

object_name: DS Stage III Plasma Cell Myeloma


subject: CHEBI:201431

object_name: Plasma cell myeloma refractory


subject: CHEBI:201431

object_name: Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: CHEBI:201431

object_name: recurrent cutaneous T-cell lymphoma


subject: CHEBI:201431

object_name: testicular lymphoma


subject: CHEBI:201431

object_name: intraocular lymphoma


subject: CHEBI:201431

object_name: Recurrent Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:201431

object_name: nodal marginal zone B-cell lymphoma


subject: CHEBI:201431

object_name: Adult T-cell lymphoma/leukaemia recurrent


subject: CHEBI:201431

object_name: Adult Anaplastic Large Cell Lymphoma


subject: CHEBI:201431

object_name: Childhood Anaplastic Large Cell Lymphoma


subject: CHEBI:201431

object_name: anaplastic large cell lymphoma


subject: CHEBI:201431

object_name: Mantle cell lymphoma recurrent


subject: CHEBI:201431

object_name: small intestine lymphoma


subject: CHEBI:201431

object_name: refractory hairy cell leukemia


subject: CHEBI:201431

object_name: angioimmunoblastic T-cell lymphoma


subject: CHEBI:201431

object_name: hepatosplenic T-cell lymphoma


subject: CHEBI:201431

object_name: Recurrent Adult Immunoblastic Lymphoma


subject: CHEBI:201431

object_name: Recurrent Grade 2 Follicular Lymphoma


subject: CHEBI:201431

object_name: Recurrent Grade 1 Follicular Lymphoma


subject: CHEBI:201431

object_name: Recurrent Grade 3 Follicular Lymphoma


subject: CHEBI:201431

object_name: splenic marginal zone lymphoma


subject: CHEBI:201431

object_name: MALT lymphoma


subject: CHEBI:201431

object_name: Marginal zone lymphoma recurrent


subject: CHEBI:201431

object_name: Recurrent Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:201431

object_name: Recurrent Adult Diffuse Large Cell Lymphoma


subject: CHEBI:201431

object_name: Recurrent Adult Burkitt Lymphoma


subject: CHEBI:201431

object_name: noncutaneous extranodal lymphoma


subject: CHEBI:201431

object_name: adult nasal type extranodal NK/T-cell lymphoma


subject: CHEBI:201431

object_name: Recurrent Adult Grade III Lymphomatoid Granulomatosis


subject: CHEBI:201431

object_name: Mycosis fungoides/Sezary syndrome recurrent


subject: CHEBI:201431

object_name: Waldenstrom macroglobulinemia


subject: CHEBI:4031

subject_name: Cyclosporine

object_name: mature T-cell and NK-cell non-Hodgkin lymphoma


subject: CHEBI:4031

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: CHEBI:4031

object_name: DS Stage II Plasma Cell Myeloma


subject: CHEBI:4031

object_name: ISS Stage II Plasma Cell Myeloma


subject: CHEBI:4031

object_name: primary cutaneous B-cell lymphoma


subject: CHEBI:4031

object_name: ISS Stage III Plasma Cell Myeloma


subject: CHEBI:4031

object_name: DS Stage III Plasma Cell Myeloma


subject: CHEBI:4031

object_name: Plasma cell myeloma refractory


subject: CHEBI:4031

object_name: Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: CHEBI:4031

object_name: recurrent cutaneous T-cell lymphoma


subject: CHEBI:4031

object_name: testicular lymphoma


subject: CHEBI:4031

object_name: intraocular lymphoma


subject: CHEBI:4031

object_name: Recurrent Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:4031

object_name: nodal marginal zone B-cell lymphoma


subject: CHEBI:4031

object_name: Adult T-cell lymphoma/leukaemia recurrent


subject: CHEBI:4031

object_name: Adult Anaplastic Large Cell Lymphoma


subject: CHEBI:4031

object_name: Childhood Anaplastic Large Cell Lymphoma


subject: CHEBI:4031

object_name: anaplastic large cell lymphoma


subject: CHEBI:4031

object_name: Mantle cell lymphoma recurrent


subject: CHEBI:4031

object_name: small intestine lymphoma


subject: CHEBI:4031

object_name: refractory hairy cell leukemia


subject: CHEBI:4031

object_name: angioimmunoblastic T-cell lymphoma


subject: CHEBI:4031

object_name: hepatosplenic T-cell lymphoma


subject: CHEBI:4031

object_name: Recurrent Adult Immunoblastic Lymphoma


subject: CHEBI:4031

object_name: Recurrent Grade 2 Follicular Lymphoma


subject: CHEBI:4031

object_name: Recurrent Grade 1 Follicular Lymphoma


subject: CHEBI:4031

object_name: Recurrent Grade 3 Follicular Lymphoma


subject: CHEBI:4031

object_name: splenic marginal zone lymphoma


subject: CHEBI:4031

object_name: MALT lymphoma


subject: CHEBI:4031

object_name: Marginal zone lymphoma recurrent


subject: CHEBI:4031

object_name: Recurrent Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:4031

object_name: Recurrent Adult Diffuse Large Cell Lymphoma


subject: CHEBI:4031

object_name: Recurrent Adult Burkitt Lymphoma


subject: CHEBI:4031

object_name: noncutaneous extranodal lymphoma


subject: CHEBI:4031

object_name: adult nasal type extranodal NK/T-cell lymphoma


subject: CHEBI:4031

object_name: Recurrent Adult Grade III Lymphomatoid Granulomatosis


subject: CHEBI:4031

object_name: Mycosis fungoides/Sezary syndrome recurrent


subject: CHEBI:4031

object_name: Waldenstrom macroglobulinemia


subject: CHEBI:168396

subject_name: Mycophenolic acid

object_name: ISS Stage II Plasma Cell Myeloma


subject: CHEBI:168396

object_name: ISS Stage III Plasma Cell Myeloma


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:8764


subject: UMLS:C5700219

subject_name: Therapeutic allogeneic lymphocytes

object_name: Chronic lymphocytic leukaemia refractory


subject: UMLS:C5700219

object_name: mature T-cell and NK-cell non-Hodgkin lymphoma


subject: UMLS:C5700219

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: UMLS:C5700219

object_name: DS Stage II Plasma Cell Myeloma


subject: UMLS:C5700219


subject: UMLS:C5700219

object_name: primary cutaneous B-cell lymphoma


subject: UMLS:C5700219


subject: UMLS:C5700219

object_name: DS Stage III Plasma Cell Myeloma


subject: UMLS:C5700219

object_name: Plasma cell myeloma refractory


subject: UMLS:C5700219

object_name: B-cell small lymphocytic lymphoma recurrent


subject: UMLS:C5700219

object_name: Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: UMLS:C5700219

object_name: recurrent cutaneous T-cell lymphoma


subject: UMLS:C5700219

object_name: testicular lymphoma


subject: UMLS:C5700219

object_name: intraocular lymphoma


subject: UMLS:C5700219

object_name: Recurrent Adult Diffuse Mixed Cell Lymphoma


subject: UMLS:C5700219

object_name: nodal marginal zone B-cell lymphoma


subject: UMLS:C5700219

object_name: Recurrent Adult Lymphoblastic Lymphoma


subject: UMLS:C5700219

object_name: Adult T-cell lymphoma/leukaemia recurrent


subject: UMLS:C5700219

object_name: Adult Anaplastic Large Cell Lymphoma


subject: UMLS:C5700219

object_name: Childhood Anaplastic Large Cell Lymphoma


subject: UMLS:C5700219

object_name: anaplastic large cell lymphoma


subject: UMLS:C5700219

object_name: Mantle cell lymphoma recurrent


subject: UMLS:C5700219

object_name: small intestine lymphoma


subject: UMLS:C5700219

object_name: refractory hairy cell leukemia


subject: UMLS:C5700219

object_name: Recurrent Adult Acute Lymphoblastic Leukemia


subject: UMLS:C5700219

object_name: angioimmunoblastic T-cell lymphoma


subject: UMLS:C5700219

object_name: hepatosplenic T-cell lymphoma


subject: UMLS:C5700219

object_name: Recurrent Adult Immunoblastic Lymphoma


subject: UMLS:C5700219

object_name: Recurrent Grade 2 Follicular Lymphoma


subject: UMLS:C5700219

object_name: Recurrent Grade 1 Follicular Lymphoma


subject: UMLS:C5700219

object_name: Recurrent Grade 3 Follicular Lymphoma


subject: UMLS:C5700219

object_name: splenic marginal zone lymphoma


subject: UMLS:C5700219

object_name: MALT lymphoma


subject: UMLS:C5700219

object_name: Marginal zone lymphoma recurrent


subject: UMLS:C5700219

object_name: Recurrent Adult Diffuse Small Cleaved Cell Lymphoma


subject: UMLS:C5700219

object_name: Recurrent Adult Diffuse Large Cell Lymphoma


subject: UMLS:C5700219

object_name: Recurrent Adult Burkitt Lymphoma


subject: UMLS:C5700219

object_name: noncutaneous extranodal lymphoma


subject: UMLS:C5700219

object_name: adult nasal type extranodal NK/T-cell lymphoma


subject: UMLS:C5700219

object_name: Recurrent Adult Grade III Lymphomatoid Granulomatosis


subject: UMLS:C5700219

object_name: Mycosis fungoides/Sezary syndrome recurrent


subject: UMLS:C5700219

object_name: Waldenstrom macroglobulinemia


subject: CHEBI:231683

subject_name: Anakinra

object_name: type 1 diabetes mellitus 1


subject: CHEBI:231683

object_name: type 1 diabetes mellitus


subject: UNII:9013DUQ28K


subject: UNII:9013DUQ28K


subject: PR:000001137

subject_name: interleukin-1 receptor antagonist protein


subject: PR:000001137


subject: UMLS:C4043002

subject_name: peginterferon lambda-1a

object_name: Hepatitis D, Chronic


subject: GTOPDB:10077

subject_name: tadekinig alfa

object_name: X-linked lymphoproliferative disease due to XIAP deficiency


subject: CHEMBL.COMPOUND:CHEMBL2108054

subject_name: TADEKINIG ALFA


subject: UNII:739DM5514X

object_name: bipolar disorder


subject: CHEBI:66919

subject_name: Ruxolitinib

object_name: psoriasis


subject: CHEBI:23456

subject_name: cyclodextrin

object_name: Cough


subject: CHEBI:23456

object_name: Cough, CTCAE


subject: UMLS:C3854029

subject_name: antiseptics ethanol

object_name: Childhood Neuroblastoma


subject: UMLS:C3854029

object_name: neuroblastoma


subject: UMLS:C3854030

subject_name: CNS depressants ethanol


subject: UMLS:C3854030


subject: CHEBI:16236

subject_name: Ethanol


subject: CHEBI:16236


subject: UNII:72W09924WP

subject_name: Asoprisnil

object_name: endometriosis


subject: UMLS:C4745058

subject_name: Copper Cu 64-CB-TE1A1P-PEG4-LLP2A

object_name: plasma cell myeloma


subject: UMLS:C4745058

object_name: Lymphoma, Low-Grade


subject: UMLS:C4745058

object_name: marginal zone lymphoma


subject: UMLS:C4745058

object_name: MALT lymphoma


subject: UMLS:C4745058

object_name: follicular lymphoma


subject: UMLS:C4745058

object_name: B-cell chronic lymphocytic leukemia


subject: UMLS:C4745058

object_name: lymphoplasmacytic lymphoma


subject: UMLS:C4745058

object_name: Waldenstrom macroglobulinemia


subject: UNII:K1YX059ML1

subject_name: Apricitabine

object_name: HIV infection


subject: UNII:4EQZ6YO2HI

subject_name: Denosumab

object_name: Immunosuppression


subject: UNII:4EQZ6YO2HI

object_name: Decreased Immunologic Activity [PE]


subject: UNII:4EQZ6YO2HI

object_name: type IV hypersensitivity disease


subject: UMLS:C1530450

subject_name: AMG 162


subject: UMLS:C1530450


subject: UMLS:C1530450


subject: CHEBI:135901

subject_name: lanreotide

object_name: carcinoid syndrome


subject: UMLS:C0051846

subject_name: angiopeptin


subject: CHEBI:9130

subject_name: Sevoflurane

object_name: Catheter site discomfort


subject: CHEBI:9130

object_name: complication


subject: UMLS:C3898831

subject_name: Hyperpolarized Carbon C 13 Pyruvate

object_name: cardiovascular disorder


subject: UMLS:C3898831

object_name: Cardiometabolic Syndrome


subject: UMLS:C3898831

object_name: abdominal obesity-metabolic syndrome


subject: UMLS:C3898831

object_name: heart failure


subject: UMLS:C3898831

object_name: Heart Failure, CTCAE


subject: UMLS:C0962969

subject_name: RAD 001

object_name: fallopian tube carcinoma


subject: UMLS:C0962969

object_name: fallopian tube cancer


subject: UMLS:C0962969

object_name: ovarian cancer


subject: UMLS:C0962969

object_name: ovarian neoplasm


subject: UMLS:C0962969

object_name: ovarian carcinoma


subject: UMLS:C0962969

object_name: primary peritoneal carcinoma


subject: UMLS:C0962969

object_name: papillary serous cystadenocarcinoma


subject: UMLS:C0962969

object_name: peritoneal carcinoma


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus


subject: PUBCHEM.COMPOUND:70789204


subject: PUBCHEM.COMPOUND:70789204


subject: PUBCHEM.COMPOUND:70789204


subject: PUBCHEM.COMPOUND:70789204


subject: PUBCHEM.COMPOUND:70789204


subject: PUBCHEM.COMPOUND:70789204


subject: PUBCHEM.COMPOUND:70789204


subject: PUBCHEM.COMPOUND:46874763

object_name: Snoring


subject: PUBCHEM.COMPOUND:46874763

object_name: streptococcal sore throat


subject: UMLS:C0003232

subject_name: Antibiotics


subject: UMLS:C0003232


subject: UNII:37KZM6S21G

subject_name: cerebrolysin

object_name: Language Delay


subject: UNII:37KZM6S21G

object_name: Mental handicap


subject: UMLS:C0055108


subject: UMLS:C0055108


subject: UNII:V7FWP1D62O

subject_name: NERVE GROWTH FACTOR


subject: UNII:V7FWP1D62O


subject: CHEBI:8884

subject_name: Rocuronium

object_name: pharyngitis


subject: CHEBI:8884

object_name: Pharyngalgia


subject: CHEBI:8884

object_name: Sore Throat, CTCAE


subject: CHEBI:177883


subject: CHEBI:177883


subject: CHEBI:177883


subject: UMLS:C3827032

subject_name: Catequentinib Hydrochloride

object_name: small cell carcinoma


subject: CHEBI:4911

subject_name: Etoposide


subject: PUBCHEM.COMPOUND:70105374

subject_name: Pitavastatin Lactone

object_name: abdominal obesity-metabolic syndrome


subject: PUBCHEM.COMPOUND:70105374

object_name: metabolic syndrome X


subject: CHEBI:32020

subject_name: Pitavastatin


subject: CHEBI:32020


subject: CHEBI:27547

subject_name: Zeaxanthin

object_name: wet macular degeneration


subject: UNII:EJB8KD4JLL

object_name: Endotoxemia


subject: UNII:EJB8KD4JLL

object_name: Systemic inflammatory response


subject: UMLS:C4079739


subject: UMLS:C4079739


subject: CHEBI:5165

subject_name: Fosphenytoin

object_name: Injuries, Acute Brain


subject: CHEBI:5165

object_name: traumatic encephalopathy


subject: CHEBI:5165

object_name: brain ischemia


subject: CHEBI:5165

object_name: brain hypoxia


subject: CHEBI:5165

object_name: Coma


subject: CHEBI:5165

object_name: brain hypoxia - ischemia


subject: CHEBI:5165

object_name: Intracranial hemorrhage


subject: CHEBI:5165

object_name: cardiac arrest


subject: CHEBI:5165

object_name: stroke disorder


subject: CHEBI:5165

object_name: cerebrovascular disorder


subject: CHEBI:5165

object_name: Stroke (heart beat)


subject: CHEBI:5165

object_name: Stroke, CTCAE


subject: CHEBI:5165

object_name: ocular motor apraxia, Cogan type


subject: CHEBI:176724

subject_name: Etiracetam


subject: CHEBI:176724


subject: CHEBI:176724


subject: CHEBI:176724


subject: CHEBI:176724


subject: CHEBI:176724


subject: CHEBI:176724


subject: CHEBI:176724


subject: CHEBI:176724


subject: CHEBI:176724


subject: CHEBI:176724


subject: CHEBI:176724


subject: CHEBI:176724


subject: UNII:73HC18Y1LW

subject_name: LEVITIRACETAM


subject: UNII:73HC18Y1LW


subject: UNII:73HC18Y1LW


subject: UNII:73HC18Y1LW


subject: UNII:73HC18Y1LW


subject: UNII:73HC18Y1LW


subject: UNII:73HC18Y1LW


subject: UNII:73HC18Y1LW


subject: UNII:73HC18Y1LW


subject: UNII:73HC18Y1LW


subject: UNII:73HC18Y1LW


subject: UNII:73HC18Y1LW


subject: UNII:73HC18Y1LW


subject: CHEBI:6437

subject_name: Levetiracetam


subject: CHEBI:6437


subject: CHEBI:6437


subject: CHEBI:6437


subject: CHEBI:6437


subject: CHEBI:6437


subject: CHEBI:6437


subject: CHEBI:6437


subject: CHEBI:6437


subject: CHEBI:6437


subject: CHEBI:6437


subject: CHEBI:6437


subject: CHEBI:6437


subject: UMLS:C2080467

subject_name: Phenobarbital Sodium Liquid Injection


subject: UMLS:C2080467


subject: UMLS:C2080467


subject: UMLS:C2080467


subject: UMLS:C2080467


subject: UMLS:C2080467


subject: UMLS:C2080467


subject: UMLS:C2080467


subject: UMLS:C2080467


subject: UMLS:C2080467


subject: UMLS:C2080467


subject: UMLS:C2080467


subject: UMLS:C2080467


subject: CHEBI:8069

subject_name: Phenobarbital


subject: CHEBI:8069


subject: CHEBI:8069


subject: CHEBI:8069


subject: CHEBI:8069


subject: CHEBI:8069


subject: CHEBI:8069


subject: CHEBI:8069


subject: CHEBI:8069


subject: CHEBI:8069


subject: CHEBI:8069


subject: CHEBI:8069


subject: CHEBI:8069


subject: CHEBI:39867

subject_name: Valproic acid


subject: CHEBI:39867


subject: CHEBI:39867


subject: CHEBI:39867


subject: CHEBI:39867


subject: CHEBI:39867


subject: CHEBI:39867


subject: CHEBI:39867


subject: CHEBI:39867


subject: CHEBI:39867


subject: CHEBI:39867


subject: CHEBI:39867


subject: CHEBI:39867


subject: PUBCHEM.COMPOUND:21634109

subject_name: Lacosamide


subject: PUBCHEM.COMPOUND:21634109


subject: PUBCHEM.COMPOUND:21634109


subject: PUBCHEM.COMPOUND:21634109


subject: PUBCHEM.COMPOUND:21634109


subject: PUBCHEM.COMPOUND:21634109


subject: PUBCHEM.COMPOUND:21634109


subject: PUBCHEM.COMPOUND:21634109


subject: PUBCHEM.COMPOUND:21634109


subject: PUBCHEM.COMPOUND:21634109


subject: PUBCHEM.COMPOUND:21634109


subject: PUBCHEM.COMPOUND:21634109


subject: PUBCHEM.COMPOUND:21634109


subject: CHEBI:5778

subject_name: Hydrochlorothiazide

object_name: Gitelman syndrome


subject: CHEBI:4907

subject_name: Etidronic acid

object_name: osteoporosis


subject: CHEBI:4907

object_name: Encounter due to family history of osteoporosis


subject: CHEBI:4907

object_name: Osteoporosis, CTCAE 5.0


subject: CHEBI:4907

object_name: Osteoporosis, CTCAE 3.0


subject: CHEBI:44915

subject_name: Propofol

object_name: colorectal cancer


subject: CHEBI:44915

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:9130

subject_name: Sevoflurane


subject: CHEBI:9130

object_name: colorectal carcinoma


subject: CHEBI:9130


subject: CHEMBL.COMPOUND:CHEMBL5314341

subject_name: GLUCAGON

object_name: type 1 diabetes mellitus 1


subject: UNII:82W826FL6S

subject_name: MILCICLIB MALEATE

object_name: liver carcinoma


subject: UNII:688000M8S8

subject_name: MILCICLIB


subject: CHEBI:49040

subject_name: Ezetimibe

object_name: prostate carcinoma


subject: CHEBI:49040

object_name: prostate cancer


subject: PUBCHEM.COMPOUND:9832423

subject_name: Vytorin


subject: PUBCHEM.COMPOUND:9832423


subject: RXCUI:476348

subject_name: ezetimibe / simvastatin Oral Tablet


subject: RXCUI:476348


subject: CHEBI:84500

subject_name: varenicline

object_name: dry eye syndrome


subject: CHEBI:84500

object_name: Dry Eye, CTCAE


subject: CHEBI:84500

object_name: Dryness of eye


subject: CHEBI:84500

object_name: Sicca Syndrome


subject: UMLS:C4726576

subject_name: Bet inhibitor cc-90010

object_name: lymphoma, non-Hodgkin, familial


subject: UMLS:C4726576

object_name: non-Hodgkin lymphoma


subject: UMLS:C4726576

object_name: neoplasm


subject: GTOPDB:9592

subject_name: tislelizumab

object_name: nasopharyngeal carcinoma


subject: GTOPDB:9592

object_name: nasopharyngeal carcinoma, susceptibility to, 1


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: CHEBI:85078

subject_name: Dapagliflozin

object_name: lupus nephritis


subject: PUBCHEM.COMPOUND:5281767

subject_name: CURCUMIN

object_name: chronic obstructive pulmonary disease


subject: UNII:KNM216XOUH

object_name: anxiety disorder


subject: UMLS:C3500879


subject: CHEBI:52717

subject_name: Bortezomib

object_name: TRANSPLANTS AND IMPLANTS


subject: CHEBI:125354

subject_name: Plerixafor


subject: CHEBI:72317

subject_name: Cabozantinib

object_name: Advanced renal cell carcinoma


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Stage III Diffuse Large B-Cell Lymphoma


subject: CHEBI:4026

object_name: Stage I Diffuse Large B-Cell Lymphoma


subject: CHEBI:4026

object_name: Stage II Diffuse Large B-Cell Lymphoma


subject: CHEBI:4026

object_name: Stage IV Diffuse Large B-Cell Lymphoma


subject: CHEBI:4026

object_name: primary effusion lymphoma


subject: CHEBI:4026

object_name: AIDS-Related Primary Effusion Lymphoma


subject: CHEBI:4026

object_name: AIDS-Related Plasmablastic Lymphoma


subject: CHEBI:4026

object_name: Ann Arbor Stage III Grade 3 Follicular Lymphoma


subject: CHEBI:4026

object_name: Ann Arbor Stage II Grade 3 Non-Contiguous Follicular Lymphoma


subject: CHEBI:4026

object_name: Ann Arbor Stage II Grade 3 Contiguous Follicular Lymphoma


subject: CHEBI:4026

object_name: Ann Arbor Stage I Grade 3 Follicular Lymphoma


subject: CHEBI:4026

object_name: Ann Arbor Stage IV Grade 3 Follicular Lymphoma


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872

object_name: Recurrent Grade 3 Follicular Lymphoma


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911

object_name: HIV infection


subject: CHEBI:8382

subject_name: Prednisone


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UNII:T5IRO3534A

subject_name: Oncovin

object_name: Diffuse large B-cell lymphoma recurrent


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: PUBCHEM.COMPOUND:3717450

subject_name: Leurocristine


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:45716

subject_name: Vorinostat


subject: CHEBI:45716


subject: CHEBI:45716


subject: CHEBI:45716


subject: CHEBI:45716


subject: CHEBI:45716


subject: CHEBI:45716


subject: CHEBI:45716


subject: CHEBI:45716

object_name: plasmablastic lymphoma


subject: CHEBI:45716

object_name: large-cell immunoblastic lymphoma


subject: CHEBI:45716


subject: CHEBI:45716


subject: CHEBI:45716


subject: PR:000016622

subject_name: tRNA (cytosine-5-)-methyltransferase

object_name: anxiety


subject: PR:000016622

object_name: anxiety disorder


subject: PR:000016622

object_name: Anxiety symptoms


subject: PR:000016622

object_name: Anxiety, CTCAE 3.0


subject: PR:000016622

object_name: Anxiety, CTCAE 5.0


subject: PR:000016622

object_name: endogenous depression


subject: PR:000016622

object_name: major depressive disorder


subject: UNII:6H81G454I7

object_name: nicotine dependence


subject: CHEBI:6519

subject_name: Lomotil

object_name: adult lymphoma


subject: CHEBI:6519

object_name: lymphoma


subject: CHEBI:6519

object_name: pediatric lymphoma


subject: RXCUI:28874


subject: RXCUI:28874


subject: RXCUI:28874


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: pancreatic adenocarcinoma


subject: CHEBI:6149

subject_name: Levobupivacaine

object_name: Childhood Breast Carcinoma


subject: CHEBI:6149

object_name: breast carcinoma


subject: CHEBI:6149

object_name: breast cancer


subject: PUBCHEM.COMPOUND:11203270

object_name: schizophrenia


subject: UNII:K1WO7H97QZ


subject: DRUGBANK:DB05687


subject: UNII:J9J6NK6W4U

object_name: intermittent vascular claudication


subject: UNII:6897GXD6OE

object_name: methemoglobinemia


subject: UNII:6897GXD6OE

object_name: Methemoglobinemia, CTCAE


subject: UMLS:C2984024

subject_name: Ferric Carboxymaltose Solution


subject: UMLS:C2984024


subject: CHEBI:28915

subject_name: Fosfomycin


subject: CHEBI:28915


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: pneumonia


subject: CHEBI:73604

object_name: COVID-19-Associated Pneumonia


subject: CHEBI:73604

object_name: viral respiratory tract infection


subject: CHEBI:73604

object_name: acute respiratory distress syndrome


subject: CHEBI:73604

object_name: adult acute respiratory distress syndrome


subject: CHEBI:8382

object_name: Myasthenia Gravis, Generalized


subject: CHEBI:8378

subject_name: Prednisolone


subject: UNII:C3VX249T6L

subject_name: Ravulizumab


subject: UMLS:C4086207


subject: UMLS:C1440044

subject_name: A,B

object_name: coral snake bite


subject: UMLS:C1440044

object_name: Toxic effect of coral snake venom


subject: DRUGBANK:DB16521

subject_name: Prolectin-M


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: Early Stage Breast Carcinoma


subject: DRUGBANK:DB10631

subject_name: Cranberry

object_name: multiple sclerosis


subject: DRUGBANK:DB10631

object_name: urinary tract infection


subject: DRUGBANK:DB10631

object_name: Recurrent urinary tract infections


subject: DRUGBANK:DB10631

object_name: Dysfunction of urinary bladder


subject: UMLS:C0453273

subject_name: cranberry preparation


subject: UMLS:C0453273


subject: UMLS:C0453273


subject: UMLS:C0453273


subject: UMLS:C3490330

subject_name: HPN 100

object_name: Cirrhosis


subject: UMLS:C3490330

object_name: liver cirrhosis


subject: CHEBI:134745

subject_name: Glycerol phenylbutyrate


subject: CHEBI:134745


subject: UMLS:C1440044

object_name: ovarian cancer


subject: UMLS:C1440044

object_name: ovarian neoplasm


subject: UMLS:C1440044

object_name: ovarian carcinoma


subject: UMLS:C0591295

subject_name: corsodyl

object_name: Infection and inflammatory reaction due to internal orthopedic fixation device


subject: UMLS:C0591295

object_name: Osteopenia


subject: UMLS:C2740888

subject_name: Agriflu

object_name: influenza


subject: PUBCHEM.COMPOUND:138713709

subject_name: deucravacitinib

object_name: subacute cutaneous lupus erythematosus


subject: PUBCHEM.COMPOUND:138713709

object_name: discoid lupus erythematosus


subject: CHEBI:135047

subject_name: Phenyltoloxamine

object_name: impotence


subject: CHEBI:135047

object_name: Erectile Dysfunction, CTCAE


subject: CHEBI:135047

object_name: Erectile dysfunction


subject: PR:000010988

subject_name: cytosolic iron-sulfur assembly component 3


subject: PR:000010988


subject: PR:000010988


subject: UniProtKB:P14283

subject_name: PERT_BORPE Pertactin autotransporter (sprot)


subject: UniProtKB:P14283


subject: UniProtKB:P14283


subject: PUBCHEM.COMPOUND:1971

subject_name: ent-Abacavir

object_name: hepatitis B


subject: CHEBI:421707

subject_name: Abacavir


subject: CHEBI:490877

subject_name: Didanosine


subject: CHEBI:119486

subject_name: Efavirenz


subject: CHEBI:63624

subject_name: Telbivudine

object_name: HIV infection


subject: CHEBI:41423

subject_name: Celecoxib

object_name: spondyloarthropathy


subject: CHEBI:35457

subject_name: EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor

object_name: hypertension, pregnancy-induced


subject: CHEBI:35457

object_name: Maternal hypertension


subject: CHEBI:35457

object_name: preeclampsia postpartum


subject: UMLS:C0003015


subject: UMLS:C0003015


subject: UMLS:C0003015


subject: CHEBI:35498

subject_name: diuretic


subject: CHEBI:35498


subject: CHEBI:35498


subject: UMLS:C0012798

subject_name: Diuretics


subject: UMLS:C0012798


subject: UMLS:C0012798


subject: UMLS:C5238470

subject_name: Pegylated SN-38 Conjugate PLX038

object_name: neoplasm


subject: UMLS:C5238470

object_name: cancer


subject: CHEBI:72317

subject_name: Cabozantinib

object_name: urothelial carcinoma


subject: CHEBI:72317

object_name: transitional cell carcinoma


subject: CHEBI:72317

object_name: urethra neoplasm


subject: CHEBI:72317

object_name: kidney neoplasm


subject: CHEBI:72317

object_name: kidney cancer


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: Guillain-Barre syndrome


subject: CHEBI:6888

object_name: Guillain-Barre Syndrome, CTCAE


subject: UNII:MRL3739G66

subject_name: Dotatate

object_name: Childhood Ganglioneuroblastoma


subject: UNII:MRL3739G66

object_name: ganglioneuroblastoma


subject: UNII:MRL3739G66

object_name: ganglioneuroma


subject: UNII:MRL3739G66

object_name: gangliocytoma


subject: UMLS:C3493499

object_name: Alzheimer disease


subject: UMLS:C3493499

object_name: Presenile dementia


subject: UMLS:C3493499

object_name: dementia


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina

object_name: type 2 diabetes mellitus


subject: PUBCHEM.COMPOUND:2735

object_name: Diabetes


subject: PUBCHEM.COMPOUND:2735

object_name: diabetes mellitus


subject: PUBCHEM.COMPOUND:2735

object_name: Depressed mood


subject: PUBCHEM.COMPOUND:2735

object_name: Cancer patients and suicide and depression


subject: PUBCHEM.COMPOUND:2735

object_name: Depressed - symptom


subject: PUBCHEM.COMPOUND:2735

object_name: Depression, CTCAE


subject: PUBCHEM.COMPOUND:2735

object_name: outcomes general quality of life


subject: PUBCHEM.COMPOUND:2735

object_name: Perceived quality of life


subject: PUBCHEM.COMPOUND:2735

object_name: Good quality of life


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: PUBCHEM.COMPOUND:10883523


subject: PUBCHEM.COMPOUND:10883523


subject: PUBCHEM.COMPOUND:10883523


subject: PUBCHEM.COMPOUND:10883523


subject: PUBCHEM.COMPOUND:10883523


subject: PUBCHEM.COMPOUND:10883523


subject: PUBCHEM.COMPOUND:10883523


subject: PUBCHEM.COMPOUND:10883523


subject: PUBCHEM.COMPOUND:10883523


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: CHEBI:27300


subject: CHEBI:27300


subject: CHEBI:27300


subject: CHEBI:27300


subject: CHEBI:27300


subject: CHEBI:62880

subject_name: Veliparib

object_name: Childhood Breast Carcinoma


subject: CHEBI:62880

object_name: breast carcinoma


subject: CHEBI:62880

object_name: breast cancer


subject: UNII:VUW370O5QE

subject_name: Cancidas

object_name: candidiasis


subject: PUBCHEM.COMPOUND:3035406

subject_name: Caspofungin


subject: UMLS:C1145191

subject_name: INJECTION, CASPOFUNGIN ACETATE, 5 MG


subject: UMLS:C0935942


subject: CHEBI:168243

subject_name: Valproic acid glucuronide

object_name: bladder tumor


subject: CHEBI:168243

object_name: urinary bladder carcinoma


subject: CHEBI:168243

object_name: urinary bladder cancer


subject: CHEBI:168243

object_name: childhood bladder carcinoma


subject: CHEBI:168243

object_name: Hematuria, CTCAE


subject: CHEBI:168243

object_name: Hematuria


subject: CHEBI:39867

subject_name: Valproic acid


subject: CHEBI:39867


subject: CHEBI:39867


subject: CHEBI:39867


subject: CHEBI:39867


subject: CHEBI:39867


subject: UNII:3A3U0GI71G

subject_name: Magnesium oxide

object_name: pseudoxanthoma elasticum (inherited or acquired)


subject: UNII:3A3U0GI71G

object_name: elastoma


subject: UNII:3A3U0GI71G

object_name: autosomal recessive inherited pseudoxanthoma elasticum


subject: CHEBI:31794

subject_name: magnesium oxide


subject: CHEBI:31794


subject: CHEBI:31794


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: spastic cerebral palsy


subject: CHEBI:231679

subject_name: ipilimumab

object_name: fallopian tube cancer


subject: CHEBI:231679

object_name: primary peritoneal carcinoma


subject: CHEBI:231679

object_name: Primary Peritoneal Cancer


subject: CHEBI:231614

subject_name: Nivolumab


subject: CHEBI:231614


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: PUBCHEM.COMPOUND:46874763

object_name: diverticulitis of colon


subject: UMLS:C0003232

subject_name: Antibiotics


subject: CHEBI:166520

subject_name: Tenamfetamine

object_name: cancer


subject: CHEBI:166520

object_name: neoplasm


subject: CHEBI:166520

object_name: adjustment disorder


subject: CHEBI:1391

subject_name: Midomafetamine


subject: CHEBI:1391


subject: CHEBI:1391


subject: UMLS:C5238410

subject_name: p97 Inhibitor CB-5339 Tosylate

object_name: Locally Advanced Malignant Solid Neoplasm


subject: UMLS:C5238410

object_name: Indolent Non-Hodgkin Lymphoma


subject: UMLS:C5238410

object_name: Indolent Adult Non-Hodgkin Lymphoma


subject: UMLS:C5238410

object_name: Aggressive Non-Hodgkin Lymphoma


subject: UMLS:C5238410

object_name: Aggressive Adult Non-Hodgkin Lymphoma


subject: UMLS:C5238410

object_name: Metastatic Malignant Solid Neoplasm


subject: CHEBI:60802

subject_name: ropivacaine

object_name: Surgical procedure, unspecified


subject: MESH:C515299

subject_name: amodiaquine, artesunate drug combination

object_name: Plasmodium falciparum malaria


subject: UNII:1GK8Z1OT1R

subject_name: FORIMTAMIG

object_name: plasma cell myeloma


subject: UMLS:C5708848

subject_name: Forimtamig


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: Locally Advanced Malignant Neoplasm


subject: PUBCHEM.COMPOUND:70789204

object_name: Her2-receptor negative breast cancer


subject: PUBCHEM.COMPOUND:70789204

object_name: Hormone receptor positive tumor


subject: CHEBI:4953

subject_name: Exemestane


subject: CHEBI:4953


subject: CHEBI:4953


subject: CHEBI:91951


subject: PUBCHEM.COMPOUND:17756771

subject_name: Fulvestrant


subject: UNII:3110E3AO8S

subject_name: Basimglurant

object_name: Depressed mood


subject: UNII:3110E3AO8S

object_name: Cancer patients and suicide and depression


subject: UNII:3110E3AO8S

object_name: Depressed - symptom


subject: UNII:3110E3AO8S

object_name: Depression, CTCAE


subject: UMLS:C4045840


subject: UMLS:C4045840


subject: UMLS:C4045840


subject: UMLS:C4045840


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: Endobronchial Mass


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: Variant Angina


subject: MESH:C000721594

object_name: binge eating


subject: UMLS:C4507515

object_name: IgA Nephropathy


subject: CHEBI:9908

subject_name: Ursolic acid

object_name: sclerosing cholangitis


subject: CHEBI:9908

object_name: primary sclerosing cholangitis


subject: PUBCHEM.COMPOUND:53477758

subject_name: Oxytocin

object_name: Birthing Labor


subject: UMLS:C0592155

subject_name: Syntocinon


subject: PUBCHEM.COMPOUND:2071

subject_name: AIDA

object_name: acute promyelocytic leukemia


subject: CHEBI:233359

object_name: High Risk Myelodysplastic Syndrome


subject: CHEBI:233359

object_name: juvenile myelomonocytic leukemia


subject: CHEBI:233359

object_name: chronic myelomonocytic leukemia


subject: CHEBI:233359

object_name: B-cell chronic lymphocytic leukemia


subject: CHEBI:233359

object_name: B-cell non-Hodgkin lymphoma


subject: CHEBI:233359

object_name: B-cell neoplasm


subject: CHEBI:233359

object_name: T-Cell Lymphoma


subject: CHEBI:233359

object_name: acute lymphoblastic leukemia


subject: CHEBI:233359

object_name: plasma cell myeloma


subject: CHEBI:233359

object_name: acute myeloid leukemia by FAB classification


subject: CHEBI:233359

object_name: acute myeloid leukemia


subject: CHEBI:233359

object_name: Richter syndrome


subject: UMLS:C4727209

subject_name: CDK9 Inhibitor AZD4573


subject: UMLS:C4727209


subject: UMLS:C4727209


subject: UMLS:C4727209


subject: UMLS:C4727209


subject: UMLS:C4727209


subject: UMLS:C4727209


subject: UMLS:C4727209


subject: UMLS:C4727209


subject: UMLS:C4727209


subject: UMLS:C4727209


subject: UMLS:C4727209


subject: UNII:CUJ2MVI71Y

subject_name: Daclizumab

object_name: psoriasis


subject: UMLS:C0281549

subject_name: Zenapax


subject: CHEBI:231614

subject_name: Nivolumab

object_name: autoimmune disease, multisystem, infantile-onset, 2


subject: CHEBI:231614

object_name: systemic sclerosis


subject: CHEBI:231614

object_name: inflammatory bowel disease


subject: CHEBI:231614

object_name: psoriatic arthritis


subject: CHEBI:231614

object_name: Sicca Syndrome


subject: CHEBI:231614

object_name: adult dermatomyositis


subject: CHEBI:231614

object_name: dermatomyositis


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C3896800

subject_name: DNA (recombinant human telomerase-specific replication-competent oncolytic adenovirus 5 vector OBP-301)

object_name: carcinoma of esophagus


subject: UMLS:C3896800

object_name: esophageal cancer


subject: UMLS:C3896800

object_name: Childhood Esophageal Carcinoma


subject: UMLS:C3896800

object_name: neoplasm of esophagus


subject: CHEBI:127342

subject_name: Atomoxetine

object_name: schizophrenia


subject: CHEBI:135925

subject_name: Lisdexamfetamine

object_name: Cognitive impairment


subject: CHEBI:135925

object_name: symptomatic menopause


subject: UMLS:C1527220

object_name: Presenile dementia


subject: UMLS:C1527220

object_name: dementia


subject: UMLS:C1527220

object_name: Alzheimer disease type 1


subject: UMLS:C1527220

object_name: Alzheimer disease


subject: CHEBI:2948

subject_name: Azathioprine

object_name: Renal transplant rejection


subject: UMLS:C0919144

subject_name: INJECTION, BASILIXIMAB, 20 MG Administered


subject: UNII:9927MT646M

subject_name: Basiliximab


subject: CHEBI:6888

subject_name: Methylprednisolone


subject: CHEBI:8382

subject_name: Prednisone


subject: CHEBI:168396

subject_name: Mycophenolic acid


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:167450

subject_name: Monomethyl fumarate


subject: CHEBI:138016

subject_name: MPA


subject: CHEBI:17026

subject_name: Progesterone


subject: CHEBI:6715

subject_name: medroxyprogesterone


subject: PR:000012478

subject_name: rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha


subject: UniProtKB:P27664

subject_name: PDE6A_MOUSE Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha (sprot)


subject: CHEBI:49900

subject_name: Arsenous acid

object_name: essential thrombocythemia


subject: CHEBI:49900

object_name: acquired polycythemia vera


subject: CHEBI:49900

object_name: myelofibrosis


subject: PUBCHEM.COMPOUND:518740

subject_name: Arsenic trioxide


subject: PUBCHEM.COMPOUND:518740


subject: PUBCHEM.COMPOUND:518740


subject: CHEBI:30621

subject_name: diarsenic trioxide


subject: CHEBI:30621


subject: CHEBI:30621


subject: UNII:S7V92P67HO


subject: UNII:S7V92P67HO


subject: UNII:S7V92P67HO


subject: CHEBI:22652

subject_name: Ascorbic acid


subject: CHEBI:22652


subject: CHEBI:22652


subject: CHEBI:59902

subject_name: ENTECAVIR

object_name: lung transplant recipient


subject: CHEBI:473990

subject_name: Entecavir


subject: CHEBI:3095

subject_name: Biguanide


subject: UMLS:C0062525

subject_name: Hyperhep B


subject: PUBCHEM.COMPOUND:6917964

subject_name: OCTREOTIDE ACETATE

object_name: Childhood Breast Carcinoma


subject: PUBCHEM.COMPOUND:6917964

object_name: breast carcinoma


subject: PUBCHEM.COMPOUND:6917964

object_name: breast cancer


subject: CHEBI:7726

subject_name: octreotide


subject: CHEBI:7726


subject: CHEBI:7726


subject: CHEBI:22198

subject_name: acetylcysteine

object_name: Rhinosinusitis


subject: CHEBI:28939

subject_name: Acetylcysteine


subject: CHEBI:17561

subject_name: Cysteine


subject: CHEBI:135515

subject_name: Bendamustine

object_name: myeloproliferative neoplasm


subject: CHEBI:135515

object_name: Malignant myeloproliferative neoplasm


subject: UNII:TT0V5JLG5B

subject_name: Avacincaptad pegol

object_name: wet macular degeneration


subject: UNII:5YV419FIJS

subject_name: sodium glycididazole

object_name: neoplasm of esophagus


subject: CHEBI:167450

subject_name: Monomethyl fumarate

object_name: Chronic Kidney Disease, CTCAE


subject: CHEBI:9570

subject_name: Thiotepa

object_name: B-cell chronic lymphocytic leukemia


subject: CHEBI:28918

subject_name: Epinephrine

object_name: hip fracture


subject: UMLS:C2350946

subject_name: APD 356

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UMLS:C2350946

object_name: obesity


subject: UMLS:C2350946

object_name: Obesity, CTCAE


subject: CHEBI:49005

subject_name: Deferasirox

object_name: Non-transfusion dependent thalassaemia


subject: UMLS:C4727789

object_name: endometriosis


subject: UMLS:C1268855

subject_name: Gonadotropin releasing hormone antagonist


subject: UMLS:C3537040

subject_name: Gonadotropin Releasing Hormone Antagonist [EPC]


subject: PUBCHEM.COMPOUND:71622431

subject_name: ivarmacitinib

object_name: rheumatoid arthritis


subject: UMLS:C5565994


subject: CHEBI:31355

subject_name: Carboplatin

object_name: Nonsquamous nonsmall cell neoplasm of lung


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: CHEBI:95021

subject_name: pemetrexed


subject: CHEBI:63724


subject: CHEBI:50790

subject_name: EC 1.14.14.14 (aromatase) inhibitor

object_name: Menopausal syndrome


subject: CHEBI:50790


subject: CHEBI:50790


subject: CHEBI:50790


subject: UMLS:C0593802

subject_name: Aromatase Inhibitors


subject: UMLS:C0593802


subject: UMLS:C0593802


subject: UMLS:C0593802


subject: UMLS:C3536820

subject_name: Aromatase Inhibitor [EPC]


subject: UMLS:C3536820


subject: UMLS:C3536820


subject: UMLS:C3536820


subject: CHEBI:93775

subject_name: Amethopterin

object_name: fibromatosis


subject: CHEBI:93775

object_name: desmoid tumor


subject: CHEBI:93775

object_name: Desmoid tumor


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:9984

subject_name: vincaleukoblastine sulfate


subject: CHEBI:9984


subject: CHEBI:9984


subject: CHEBI:27375

subject_name: Vinblastine


subject: CHEBI:27375


subject: CHEBI:27375


subject: PUBCHEM.COMPOUND:71226663

subject_name: Acalabrutinib

object_name: liver lymphoma


subject: CHEBI:135515

subject_name: Bendamustine


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide


subject: CHEBI:28680

subject_name: Cytarabine


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UMLS:C0295415

subject_name: rituximab


subject: CHEBI:31239

subject_name: Arotinolol hydrochloride

object_name: essential hypertension


subject: CHEBI:135569

subject_name: Arotinolol


subject: UMLS:C0873154

subject_name: arotinolol hydrochloride


subject: UMLS:C5432251


subject: CHEBI:57694

object_name: chronic obstructive pulmonary disease


subject: CHEBI:16243

subject_name: Quercetin


subject: UMLS:C0919144

subject_name: INJECTION, BASILIXIMAB, 20 MG Administered

object_name: extranodal nasal NK/T cell lymphoma


subject: UMLS:C0919144

object_name: Lymphoma, Extranodal NK-T-Cell


subject: UNII:9927MT646M

subject_name: Basiliximab


subject: UNII:9927MT646M


subject: GTOPDB:9758

subject_name: camrelizumab

object_name: adult lymphoma


subject: GTOPDB:9758

object_name: lymphoma


subject: GTOPDB:9758

object_name: pediatric lymphoma


subject: GTOPDB:9758

object_name: Recurrence


subject: UNII:73096E137E


subject: UNII:73096E137E


subject: UNII:73096E137E


subject: UNII:73096E137E


subject: UMLS:C4085979


subject: UMLS:C4085979


subject: UMLS:C4085979


subject: UMLS:C4085979


subject: CHEBI:9168

subject_name: Sirolimus

object_name: myxoid liposarcoma


subject: CHEBI:9168

object_name: myxoid/round cell liposarcoma


subject: CHEBI:9168

object_name: dedifferentiated chondrosarcoma


subject: CHEBI:9168

object_name: mesenchymal chondrosarcoma


subject: CHEBI:9168

object_name: pediatric mesenchymal chondrosarcoma


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:232617

object_name: Community-Acquired Pneumonia


subject: CHEBI:232617

object_name: COVID-19-Associated Pneumonia


subject: CHEBI:232617

object_name: Pneumonia and influenza


subject: UMLS:C2830136


subject: UMLS:C2830136


subject: UMLS:C2830136


subject: UMLS:C0525959

object_name: Carcinoma breast stage IV


subject: UMLS:C0525959

object_name: estrogen-receptor positive breast cancer


subject: UMLS:C0525959

object_name: breast neoplasm


subject: CHEBI:23965

subject_name: estradiol


subject: CHEBI:23965


subject: CHEBI:23965


subject: UMLS:C5432260

subject_name: Tesnatilimab

object_name: alopecia areata


subject: UMLS:C5432260

object_name: alopecia


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: adult germ cell tumor


subject: PUBCHEM.COMPOUND:70789204

object_name: germ cell tumor


subject: PUBCHEM.COMPOUND:70789204

object_name: childhood germ cell tumor


subject: PUBCHEM.COMPOUND:70789204

object_name: Germ Cell Cancer


subject: CHEBI:15355

subject_name: Acetylcholine

object_name: cardiac allograft vasculopathy


subject: CHEBI:15355

object_name: Antibody-mediated rejection


subject: CHEBI:5801

subject_name: Hydroxychloroquine

object_name: Hashimoto thyroiditis


subject: PUBCHEM.COMPOUND:11331256

subject_name: Amaryl M

object_name: type 2 diabetes mellitus


subject: CHEBI:151315

subject_name: Heparin

object_name: Mesenteric vascular insufficiency


subject: PUBCHEM.COMPOUND:92043599

subject_name: epoetin alfa

object_name: outcomes general quality of life


subject: PUBCHEM.COMPOUND:92043599

object_name: Perceived quality of life


subject: PUBCHEM.COMPOUND:92043599

object_name: Good quality of life


subject: PUBCHEM.COMPOUND:92043599


subject: CHEBI:76842

object_name: cystic fibrosis


subject: CHEBI:76842

object_name: methicillin-resistant staphylococcus aureus infectious disease


subject: CHEBI:28001

subject_name: Vancomycin


subject: CHEBI:28001


subject: CHEMBL.COMPOUND:CHEMBL2134724

subject_name: IPRATROPIUM BROMIDE

object_name: COPD, severe early onset


subject: CHEMBL.COMPOUND:CHEMBL2134724

object_name: chronic obstructive pulmonary disease


subject: CHEBI:5957

subject_name: ipratropium bromide hydrate


subject: CHEBI:5957


subject: UNII:J697UZ2A9J


subject: UNII:J697UZ2A9J


subject: CHEBI:205919

subject_name: Clobetasol

object_name: Dandruff


subject: UMLS:C4507303

object_name: head and neck squamous cell carcinoma


subject: UMLS:C4507303

object_name: HER2 positive breast carcinoma


subject: UMLS:C4507303

object_name: Her2-receptor negative breast cancer


subject: UMLS:C4507303

object_name: esophageal squamous cell carcinoma


subject: CHEBI:86345

subject_name: magnesium dichloride hexahydrate

object_name: type 1 diabetes mellitus 1


subject: CHEBI:86345

object_name: type 1 diabetes mellitus


subject: PUBCHEM.COMPOUND:23431961

subject_name: Sodium citrate


subject: PUBCHEM.COMPOUND:23431961


subject: CHEBI:30769

subject_name: Citric acid


subject: CHEBI:30769


subject: CHEBI:50861

subject_name: Treprostinil


subject: CHEBI:50861


subject: UNII:21P2M98388

subject_name: Henagliflozin

object_name: metabolic dysfunction-associated steatotic liver disease


subject: UMLS:C2987342

object_name: Childhood Teratoma


subject: UMLS:C2987342

object_name: adult teratoma


subject: UMLS:C2987342

object_name: teratoma


subject: CHEBI:125628

subject_name: Alisertib

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C2930557

object_name: coronary artery disorder


subject: UMLS:C2930557

object_name: coronary atherosclerosis


subject: UNII:971Z4W1S09

subject_name: Technetium Tc-99m sestamibi

object_name: Diabetes


subject: UNII:971Z4W1S09

object_name: diabetes mellitus


subject: CHEBI:33353

subject_name: technetium atom


subject: CHEBI:33353


subject: UMLS:C3540708

subject_name: Antibiotics, Gynecological

object_name: appendicitis


subject: UMLS:C3540708

object_name: Appendicitis, CTCAE


subject: UMLS:C3540708

object_name: Ruptured Appendicitis


subject: UMLS:C3540708

object_name: complicated appendicitis


subject: MESH:D000904

subject_name: Antibiotics, Antitubercular


subject: MESH:D000904


subject: MESH:D000904


subject: MESH:D000904


subject: UMLS:C3540709

subject_name: antibiotics, intestinal


subject: UMLS:C3540709


subject: UMLS:C3540709


subject: UMLS:C3540709


subject: UMLS:C3540707

subject_name: Antibiotics FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE


subject: UMLS:C3540707


subject: UMLS:C3540707


subject: UMLS:C3540707


subject: UMLS:C0003232

subject_name: Antibiotics


subject: UMLS:C0003232


subject: UMLS:C0003232


subject: UMLS:C0003232


subject: UMLS:C3540704

subject_name: Antibiotics for systemic use


subject: UMLS:C3540704


subject: UMLS:C3540704


subject: UMLS:C3540704


subject: UMLS:C3540706

subject_name: Antibiotic throat preparations


subject: UMLS:C3540706


subject: UMLS:C3540706


subject: UMLS:C3540706


subject: UMLS:C3540710

subject_name: Antibiotics, ophthalmologic


subject: UMLS:C3540710


subject: UMLS:C3540710


subject: UMLS:C3540710


subject: UMLS:C3540705

subject_name: Antifungal Antibiotics, Topical


subject: UMLS:C3540705


subject: UMLS:C3540705


subject: UMLS:C3540705


subject: CHEBI:135609

subject_name: Gusperimus

object_name: lupus nephritis


subject: UMLS:C0132640


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Radicular pain


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: toothache


subject: CHEBI:3215

object_name: Toothache, CTCAE


subject: CHEBI:53578

subject_name: hexamethylene diisocyanate

object_name: metastatic melanoma


subject: CHEBI:53578

object_name: melanoma


subject: CHEBI:53578

object_name: skin melanoma


subject: CHEBI:61115

subject_name: EC 3.5.1.98 (histone deacetylase) inhibitor


subject: CHEBI:61115


subject: CHEBI:61115


subject: UMLS:C1669509


subject: UMLS:C1669509


subject: UMLS:C1669509


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: primary peritoneal carcinoma


subject: UNII:52CMI0WC3Y

object_name: Primary Peritoneal Cancer


subject: UNII:52CMI0WC3Y

object_name: fallopian tube carcinoma


subject: UNII:52CMI0WC3Y

object_name: fallopian tube cancer


subject: UNII:52CMI0WC3Y

object_name: ovarian endometrial cancer


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab


subject: UMLS:C5908626

subject_name: Investigational Medicinal Product

object_name: epilepsy


subject: CHEBI:74061

subject_name: Ile-Arg


subject: CHEBI:49666

subject_name: iridium atom


subject: PR:000009064

subject_name: insulin receptor


subject: PR:000031465

subject_name: probable hydrolase PNKD


subject: PR:000001819

subject_name: MHC class I-related gene protein


subject: UniProtKB:P22777

subject_name: PAI1_MOUSE Plasminogen activator inhibitor 1 (sprot)


subject: PR:000014702

subject_name: plasminogen activator inhibitor 1


subject: PR:000008531

subject_name: hereditary hemochromatosis protein


subject: CHEBI:67271

object_name: Metastatic Cutaneous Melanoma


subject: CHEBI:67271

object_name: Stage IV Cutaneous Melanoma AJCC v6 and v7


subject: CHEBI:67271


subject: CHEBI:67271

object_name: stage IIIB melanoma


subject: CHEBI:67271

object_name: stage IIIA melanoma


subject: CHEBI:67271

object_name: stage IIIC melanoma


subject: CHEBI:67271

object_name: Melanoma recurrent


subject: CHEBI:90227

subject_name: Selumetinib


subject: CHEBI:90227


subject: CHEBI:90227


subject: CHEBI:90227


subject: CHEBI:90227


subject: CHEBI:90227


subject: CHEBI:90227


subject: UMLS:C3641944

subject_name: SGN CD19A

object_name: Burkitt lymphoma


subject: UMLS:C3641944

object_name: Childhood Burkitt Lymphoma


subject: UMLS:C3641944

object_name: Adult Burkitt Lymphoma


subject: UMLS:C3641944

object_name: follicular lymphoma


subject: UMLS:C3641944

object_name: mantle cell lymphoma


subject: UMLS:C3641944

object_name: Precursor B-Cell Lymphoblastic Leukemia-Lymphoma


subject: CHEBI:49086

object_name: OPTN-related open angle glaucoma


subject: CHEBI:49086

object_name: open-angle glaucoma


subject: CHEBI:16436

subject_name: Citicoline


subject: CHEBI:16436


subject: CHEBI:23359

subject_name: colchicine

object_name: In-stent coronary artery restenosis


subject: CHEBI:23359

object_name: arteriosclerosis disorder


subject: CHEBI:23359

object_name: atherosclerosis


subject: CHEBI:3423

subject_name: Carmustine

object_name: Mantle cell lymphoma refractory


subject: CHEBI:3423

object_name: T-cell lymphoma recurrent


subject: CHEBI:3423

object_name: B-cell lymphoma refractory


subject: CHEBI:3423

object_name: T-cell lymphoma refractory


subject: CHEBI:3423

object_name: Recurrent Hodgkin Lymphoma


subject: CHEBI:3423

object_name: Refractory Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide

object_name: Mantle cell lymphoma recurrent


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:82339

subject_name: Merphalan


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:28876

subject_name: Melphalan


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: UMLS:C0054066

subject_name: amoxicillin / clavulanate

object_name: chronic rhinosinusitis


subject: UMLS:C2826152

subject_name: fluorescein sodium injection

object_name: Adult Solid Neoplasm


subject: UMLS:C2826152

object_name: Postneoadjuvant Therapy Stage IV Gastric Cancer AJCC v8


subject: UMLS:C2826152

object_name: Resectable Liver Carcinoma


subject: UMLS:C2826152

object_name: Malignant Solid Neoplasm


subject: UMLS:C2826152

object_name: Metastatic Primary Malignant Brain Neoplasm


subject: UMLS:C2826152

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: UMLS:C2826152

object_name: Stage IV Hepatocellular Carcinoma AJCC v8


subject: UMLS:C2826152

object_name: Clinical Stage IV Gastric Cancer AJCC v8


subject: UMLS:C2826152

object_name: Resectable Colorectal Carcinoma


subject: UMLS:C2826152

object_name: Stage IV Colorectal Cancer AJCC v8


subject: UMLS:C2826152

object_name: Pancreas carcinoma resectable


subject: UMLS:C2826152

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: UMLS:C2826152

object_name: Resectable Gastric Carcinoma


subject: UMLS:C2826152

object_name: Resectable Breast Carcinoma


subject: UMLS:C2826152

object_name: Metastatic Colorectal Carcinoma


subject: UMLS:C2826152

object_name: Resectable Brain Neoplasm


subject: UMLS:C2826152

object_name: stage IV pancreatic cancer


subject: UMLS:C2826152

object_name: Metastatic Gastric Carcinoma


subject: UMLS:C2826152

object_name: Metastatic Breast Carcinoma


subject: UMLS:C2826152

object_name: Metastatic liver carcinoma


subject: UMLS:C2826152

object_name: Resectable Sarcoma


subject: UMLS:C2826152

object_name: brain cancer


subject: UMLS:C2826152

object_name: Metastatic sarcoma


subject: UMLS:C2916932

subject_name: Gammaplex

object_name: autoimmune thrombocytopenia


subject: UMLS:C0085297

subject_name: immunoglobulins, intravenous


subject: CHEBI:4046

subject_name: Cyproheptadine

object_name: viral pneumonia


subject: CHEBI:4046

object_name: serotonin syndrome


subject: CHEBI:4046

object_name: carcinoid syndrome


subject: CHEBI:4046

object_name: Platelet dysfunction


subject: CHEBI:8382

subject_name: Prednisone

object_name: pemphigus foliaceus


subject: CHEBI:8382

object_name: pemphigus vulgaris


subject: CHEBI:30496

subject_name: Sulfur hexafluoride

object_name: inflammatory bowel disease 1


subject: CHEBI:30496

object_name: Crohn disease


subject: CHEBI:95060

subject_name: Dinaciclib

object_name: triple-negative breast carcinoma


subject: CHEBI:95060

object_name: HER2/Neu Negative


subject: CHEBI:95060

object_name: male breast carcinoma


subject: CHEBI:95060

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: CHEBI:95060

object_name: Breast cancer recurrent


subject: CHEBI:95060

object_name: Estrogen Receptor Negative


subject: CHEBI:95060

object_name: Progesterone Receptor Negative


subject: CHEBI:47898

subject_name: Epirubicin


subject: CHEBI:47898


subject: CHEBI:47898


subject: CHEBI:47898


subject: CHEBI:47898


subject: CHEBI:47898


subject: UMLS:C1879711

subject_name: AMG 102

object_name: lung cancer


subject: UMLS:C1879711

object_name: lung neoplasm


subject: UMLS:C1879711

object_name: lung carcinoma


subject: UMLS:C1879711

object_name: small cell lung carcinoma


subject: UMLS:C1879711

object_name: Small cell lung cancer extensive stage


subject: UMLS:C1879711

object_name: Solid Neoplasm


subject: UMLS:C2744646


subject: UMLS:C2744646


subject: UMLS:C2744646


subject: UMLS:C2744646


subject: UMLS:C2744646


subject: UMLS:C2744646


subject: CHEBI:3139

subject_name: bleomycin

object_name: plantar wart


subject: UNII:1FQ2RY5YHH

subject_name: Patiromer

object_name: chronic kidney disease


subject: UNII:1FQ2RY5YHH

object_name: hypertension


subject: UNII:1FQ2RY5YHH

object_name: Hypertension, CTCAE


subject: CHEBI:36791

subject_name: Escitalopram

object_name: chronic rhinosinusitis


subject: CHEBI:3723

subject_name: Citalopram


subject: CHEBI:100241

subject_name: Ciprofloxacin

object_name: colorectal cancer


subject: CHEBI:100241

object_name: colorectal carcinoma


subject: CHEBI:100241

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UNII:3A189DH42V

subject_name: Alemtuzumab

object_name: type 1 diabetes mellitus


subject: GTOPDB:13085

subject_name: adebrelimab

object_name: Small cell lung cancer limited stage


subject: UNII:1XBY50W1OX

subject_name: ADEBRELIMAB


subject: UMLS:C4725109


subject: UNII:5S371K6132

subject_name: Rivoceranib


subject: UMLS:C4547969

subject_name: apatinib mesylate


subject: CHEBI:9943

subject_name: Venlafaxine

object_name: osteoarthritis


subject: CHEBI:37924

subject_name: Atazanavir

object_name: Endotoxemia


subject: CHEBI:37924

object_name: Inflammation


subject: CHEBI:37924

object_name: Sepsis


subject: CHEBI:37924

object_name: Sepsis, CTCAE


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: bladder tumor


subject: CHEBI:94518

object_name: urinary bladder carcinoma


subject: CHEBI:94518

object_name: urinary bladder cancer


subject: CHEBI:94518

object_name: childhood bladder carcinoma


subject: UMLS:C0003442

subject_name: lymphocyte immune globulin, anti-thymocyte globulin

object_name: acute lymphoblastic leukemia


subject: UMLS:C0003442

object_name: leukemia, acute lymphocytic, susceptibility to, 1


subject: UMLS:C0003442

object_name: acute leukemia of ambiguous lineage


subject: UMLS:C0003442

object_name: Blood alcohol concentration


subject: CHEBI:25357

subject_name: mitomycin

object_name: colorectal neoplasm


subject: CHEBI:27504

subject_name: Mitomycin


subject: GTOPDB:9758

subject_name: camrelizumab

object_name: nasopharyngeal neoplasm


subject: UNII:73096E137E


subject: UMLS:C4085979


subject: CHEBI:6456

subject_name: Lidocaine

object_name: herpes zoster


subject: CHEBI:6456

object_name: postherpetic neuralgia


subject: UMLS:C1831774

object_name: cancer


subject: UMLS:C1831774

object_name: neoplasm


subject: UMLS:C1831774

object_name: lung disorder


subject: CHEBI:31236

subject_name: Aripiprazole

object_name: post-traumatic stress disorder


subject: PUBCHEM.COMPOUND:174707

subject_name: stronger neominophagen C

object_name: liver carcinoma


subject: PUBCHEM.COMPOUND:3062

subject_name: Cogoxin

object_name: abortion


subject: CHEBI:145795


subject: CHEBI:4551

subject_name: Digoxin


subject: UNII:4RA0KN46E0

subject_name: Upadacitinib

object_name: vitiligo-associated multiple autoimmune disease susceptibility 1


subject: UNII:4RA0KN46E0

object_name: vitiligo


subject: UMLS:C4745029

subject_name: HLX 10

object_name: cervical cancer


subject: UMLS:C4745029

object_name: cervical carcinoma


subject: CHEBI:39867

subject_name: Valproic acid

object_name: asthma


subject: UMLS:C5787286

object_name: chronic lymphocytic leukemia/small lymphocytic lymphoma


subject: UMLS:C5787286

object_name: B-cell chronic lymphocytic leukemia


subject: UMLS:C5787286

object_name: lymphoma, non-Hodgkin, familial


subject: UMLS:C5787286

object_name: non-Hodgkin lymphoma


subject: UMLS:C5787286

object_name: Lymphoma, Large-Cell, Follicular


subject: UMLS:C5815502

object_name: cytomegalovirus infection


subject: UMLS:C5815501


subject: CHEBI:93235

subject_name: flupentixol

object_name: cocaine abuse


subject: CHEBI:5121

subject_name: flupenthixol


subject: CHEMBL.COMPOUND:CHEMBL3833369

subject_name: FISH OIL

object_name: heart failure


subject: CHEMBL.COMPOUND:CHEMBL3833369

object_name: Heart Failure, CTCAE


subject: CHEBI:37144

subject_name: epichlorohydrin


subject: CHEBI:37144


subject: CHEBI:28364

subject_name: Icosapent


subject: CHEBI:28364


subject: PR:000016352

subject_name: metalloproteinase inhibitor 1


subject: PR:000016352


subject: CHEBI:36005

subject_name: docosahexaenoic acid


subject: CHEBI:36005


subject: CHEBI:16016

subject_name: Glycerone


subject: CHEBI:16016


subject: CHEBI:28689

subject_name: Prasterone


subject: CHEBI:28689


subject: CHEBI:28125

subject_name: Doconexent


subject: CHEBI:28125


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UMLS:C3537249

subject_name: D Vitamin


subject: CHEBI:18220

subject_name: Isoflavone

object_name: abdominal obesity-metabolic syndrome


subject: CHEBI:18220

object_name: metabolic syndrome X


subject: CHEBI:50733

subject_name: nutraceutical


subject: CHEBI:50733


subject: CHEBI:50733

object_name: type 2 diabetes mellitus


subject: CHEBI:63577

subject_name: Lamivudine

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:63577

object_name: obesity


subject: CHEBI:63577

object_name: Obesity, CTCAE


subject: CHEBI:63717

subject_name: Tenofovir disoproxil


subject: CHEBI:63717


subject: CHEBI:63717


subject: CHEBI:63625

subject_name: Tenofovir


subject: CHEBI:63625


subject: CHEBI:63625


subject: UniProtKB:P36394

subject_name: SRY_RAT Sex-determining region Y protein (sprot)


subject: UniProtKB:P36394


subject: UniProtKB:P36394


subject: PR:000015643

subject_name: sex-determining region Y protein


subject: PR:000015643


subject: PR:000015643


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED

object_name: head and neck neoplasm


subject: UMLS:C0919079

object_name: head and neck cancer


subject: UMLS:C0919079

object_name: Neoplasm of cecum and/or colon and/or rectum


subject: UMLS:C0919079

object_name: colorectal neoplasm


subject: UMLS:C0919079

object_name: neoplasm of esophagus


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: UMLS:C4721782

subject_name: Pegargiminase

object_name: non-small cell lung carcinoma


subject: UMLS:C4721782

object_name: small cell lung carcinoma


subject: UMLS:C1328192

subject_name: ADI PEG20


subject: UMLS:C1328192


subject: CHEBI:4672

subject_name: Docetaxel


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEBI:76842

object_name: Closed Fracture


subject: CHEBI:28001

subject_name: Vancomycin


subject: CHEBI:35475

subject_name: non-steroidal anti-inflammatory drug

object_name: opioid use


subject: UMLS:C0003211

subject_name: Anti-Inflammatory Agents, Non-Steroidal


subject: UMLS:C3536840

subject_name: Nonsteroidal Anti-inflammatory Drug [EPC]


subject: CHEBI:5779

subject_name: Hydrocodone


subject: CHEBI:50692

subject_name: Mifepristone

object_name: Missed abortion


subject: CHEBI:50692

object_name: Pregnant


subject: CHEBI:66919

subject_name: Ruxolitinib

object_name: Miller-Dieker lissencephaly syndrome


subject: CHEBI:66919

object_name: myoclonic dystonia 11


subject: UNII:4I9I5X3Z6N

subject_name: VUDALIMAB

object_name: Metastatic Thyroid Gland Anaplastic Carcinoma


subject: UNII:4I9I5X3Z6N

object_name: Locally Advanced Thyroid Gland Anaplastic Carcinoma


subject: UNII:4I9I5X3Z6N

object_name: Metastatic Thyroid Gland Oncocytic Carcinoma


subject: UMLS:C4725753

subject_name: Vudalimab


subject: UMLS:C4725753


subject: UMLS:C4725753


subject: CHEBI:182913

subject_name: Dexpramipexole

object_name: adrenoleukodystrophy


subject: CHEBI:182913

object_name: X-linked cerebral adrenoleukodystrophy


subject: CHEBI:8356

subject_name: Pramipexole


subject: CHEBI:8356


subject: CHEBI:15544

subject_name: Alprostadil

object_name: type 2 diabetes mellitus


subject: CHEBI:15544

object_name: Diabetes


subject: CHEBI:15544

object_name: diabetes mellitus


subject: UNII:KXG2PJ551I

subject_name: Avelumab

object_name: recurrent respiratory papillomatosis


subject: UNII:KXG2PJ551I

object_name: Human Papilloma Virus, Female


subject: UNII:KXG2PJ551I

object_name: Human Papilloma Virus, Male


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: CHEBI:31300

subject_name: BOSENTAN


subject: CHEBI:51450

subject_name: Bosentan


subject: CHEBI:27082

subject_name: trehalose

object_name: metabolic dysfunction-associated steatotic liver disease


subject: UNII:768FW21J3L

subject_name: Famitinib

object_name: Metastatic Carcinoma to the Uterine Cervix


subject: UNII:768FW21J3L

object_name: Cervix carcinoma recurrent


subject: GTOPDB:9758

subject_name: camrelizumab


subject: GTOPDB:9758


subject: UNII:73096E137E


subject: UNII:73096E137E


subject: UMLS:C4085979


subject: UMLS:C4085979


subject: UNII:981TME683S

subject_name: Ropeginterferon alfa-2b

object_name: cellular phase chronic idiopathic myelofibrosis


subject: UMLS:C3827091


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina

object_name: Pediatric Obesity


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: UMLS:C3265062


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: Detrusor muscle hyperactivity


subject: CHEBI:145499

subject_name: Donepezil

object_name: obstructive sleep apnea syndrome


subject: UMLS:C1879771

subject_name: BIBF 1120

object_name: non-small cell lung carcinoma


subject: MESH:D002800

subject_name: Cholinesterase Inhibitors

object_name: Alzheimer disease type 1


subject: MESH:D002800

object_name: Alzheimer disease


subject: CHEBI:8874

subject_name: Rivastigmine


subject: UMLS:C4505791


subject: UMLS:C2342291

subject_name: Luvox CR

object_name: Compulsion


subject: CHEBI:6402

subject_name: Leflunomide

object_name: neuroendocrine neoplasm


subject: CHEBI:8198

subject_name: Polydatin

object_name: irritable bowel syndrome


subject: PUBCHEM.COMPOUND:57414794

subject_name: Dolutegravir

object_name: Weight Gain


subject: PUBCHEM.COMPOUND:57414794

object_name: Weight Gain, CTCAE


subject: PUBCHEM.COMPOUND:57414794

object_name: HIV lipodystrophy


subject: PUBCHEM.COMPOUND:57414794

object_name: kidney failure


subject: PUBCHEM.COMPOUND:57414794

object_name: osteoporosis


subject: PUBCHEM.COMPOUND:57414794

object_name: Encounter due to family history of osteoporosis


subject: PUBCHEM.COMPOUND:57414794

object_name: Osteoporosis, CTCAE 5.0


subject: PUBCHEM.COMPOUND:57414794

object_name: Osteoporosis, CTCAE 3.0


subject: PUBCHEM.COMPOUND:57414794

object_name: obesity due to melanocortin 4 receptor deficiency


subject: PUBCHEM.COMPOUND:57414794

object_name: obesity


subject: PUBCHEM.COMPOUND:57414794

object_name: Obesity, CTCAE


subject: UNII:913P6LK81M

subject_name: Doravirine


subject: UNII:913P6LK81M


subject: UNII:913P6LK81M


subject: UNII:913P6LK81M


subject: UNII:913P6LK81M


subject: UNII:913P6LK81M


subject: UNII:913P6LK81M


subject: UNII:913P6LK81M


subject: UNII:913P6LK81M


subject: CHEBI:63577

subject_name: Lamivudine


subject: CHEBI:63577


subject: CHEBI:63577


subject: CHEBI:63577


subject: CHEBI:63577


subject: CHEBI:63577


subject: CHEBI:63577


subject: CHEBI:63577


subject: CHEBI:139072

object_name: Encounter due to psychotherapy


subject: CHEBI:139072

object_name: cancer-related condition


subject: CHEBI:139072

object_name: Terminal illness


subject: CHEBI:139072

object_name: End stage cancer


subject: CHEBI:8614

subject_name: Psilocybin


subject: CHEBI:8614


subject: CHEBI:8614


subject: CHEBI:8614


subject: CHEBI:164200

subject_name: Triclosan

object_name: gingival disorder


subject: CHEBI:29228

subject_name: FLUORIDE


subject: CHEBI:17051

subject_name: Fluoride ion


subject: UMLS:C3541971

subject_name: Fluoride supplements


subject: UMLS:C3714616

subject_name: Fluoride Drug Class


subject: CHEBI:6504

object_name: neuroendocrine neoplasm


subject: PUBCHEM.COMPOUND:21874242

subject_name: Vinflunine

object_name: breast neoplasm


subject: UMLS:C3541386

subject_name: Estrogens, endocrine therapy drugs

object_name: Menopause present (finding)


subject: UMLS:C3541386

object_name: Menopause


subject: UMLS:C3541386

object_name: insomnia


subject: UMLS:C3541386

object_name: Insomnia, CTCAE 3.0


subject: UMLS:C3541386

object_name: Insomnia, CTCAE 5.0


subject: UMLS:C3537250

subject_name: ESTROGENS, SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM


subject: UMLS:C3537250


subject: UMLS:C3537250


subject: UMLS:C3537250


subject: UMLS:C3537250


subject: CHEBI:50114

subject_name: estrogen


subject: CHEBI:50114


subject: CHEBI:50114


subject: CHEBI:50114


subject: CHEBI:50114


subject: UMLS:C3714615

subject_name: Estrogens Drug Class


subject: UMLS:C3714615


subject: UMLS:C3714615


subject: UMLS:C3714615


subject: UMLS:C3714615


subject: UMLS:C3540025

subject_name: Progestogen systemic hormonal contraceptives


subject: UMLS:C3540025


subject: UMLS:C3540025


subject: UMLS:C3540025


subject: UMLS:C3540025


subject: CHEBI:59826

subject_name: progestin


subject: CHEBI:59826


subject: CHEBI:59826


subject: CHEBI:59826


subject: CHEBI:59826


subject: UMLS:C3540745

subject_name: PROGESTOGEN SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM


subject: UMLS:C3540745


subject: UMLS:C3540745


subject: UMLS:C3540745


subject: UMLS:C3540745


subject: UMLS:C3540744

subject_name: Progestogens, endocrine therapy drugs


subject: UMLS:C3540744


subject: UMLS:C3540744


subject: UMLS:C3540744


subject: UMLS:C3540744


subject: CHEBI:94366

subject_name: itraconazole

object_name: Gastroesophageal Junction Carcinoma


subject: CHEBI:94366

object_name: esophageal squamous cell carcinoma


subject: UNII:6QVL057INT

subject_name: Cemiplimab

object_name: oropharyngeal carcinoma


subject: UNII:6QVL057INT

object_name: oropharynx cancer


subject: UNII:6QVL057INT

object_name: Neck Carcinoma


subject: UNII:6QVL057INT

object_name: head and neck neoplasm


subject: UNII:6QVL057INT

object_name: head and neck cancer


subject: UMLS:C4053601


subject: UMLS:C4053601


subject: UMLS:C4053601


subject: UMLS:C4053601


subject: UMLS:C4053601


subject: UMLS:C5206716

object_name: squamous cell carcinoma


subject: UMLS:C5206716


subject: UMLS:C5206716


subject: UMLS:C5206716


subject: UMLS:C5206716


subject: UMLS:C5206716


subject: UMLS:C0385473

subject_name: FLUOS

object_name: colorectal cancer


subject: UMLS:C0385473

object_name: colorectal carcinoma


subject: UMLS:C0385473

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UNII:C4V974V932

subject_name: Indocyanine green acid form


subject: UNII:C4V974V932


subject: UNII:C4V974V932


subject: UNII:6A901E312A

subject_name: Panitumumab

object_name: cholangiocarcinoma


subject: UMLS:C3536908

subject_name: Omega-3 Fatty Acid [EPC]

object_name: rheumatoid arthritis


subject: CHEBI:38290

subject_name: L-ascorbate

object_name: Iron deficiency


subject: CHEBI:176783

subject_name: vitamin C


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: UMLS:C0678021

subject_name: Ad5CMV-p53 gene


subject: UMLS:C0678021


subject: UMLS:C0678021


subject: CHEBI:182913

subject_name: Dexpramipexole

object_name: Compulsion


subject: CHEBI:8356

subject_name: Pramipexole


subject: UMLS:C3896681

subject_name: Eltrapuldencel-T

object_name: liver carcinoma


subject: GTOPDB:4942

subject_name: GM-CSF


subject: UNII:5TAA004E22

subject_name: Sargramostim


subject: PR:000005931


subject: UMLS:C0376563

subject_name: Recombinant Granulocyte-Macrophage Colony-Stimulating Factors


subject: CHEBI:60787

subject_name: TIMOLOL

object_name: melanoma


subject: CHEBI:39465

subject_name: timolol


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations

object_name: non-small cell lung carcinoma


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: PUBCHEM.COMPOUND:11422859

object_name: myeloproliferative syndrome


subject: CHEBI:681569

subject_name: Clofarabine

object_name: Metastatic urothelial carcinoma


subject: CHEBI:681569

object_name: Advanced Urothelial Carcinoma


subject: UNII:UG7I3Y42PV

subject_name: Fluoroazomycin arabinoside F-18

object_name: malignant soft tissue neoplasm


subject: UNII:UG7I3Y42PV

object_name: sarcoma


subject: UMLS:C1566975


subject: UMLS:C1566975


subject: CHEBI:230386

subject_name: Pimonidazole


subject: CHEBI:230386


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: ectropion


subject: PUBCHEM.COMPOUND:14907381

object_name: skin neoplasm


subject: CHEBI:190410

subject_name: 13-Demethyl tacrolimus


subject: CHEBI:190410


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:46345


subject: UMLS:C3714111


subject: CHEBI:90237

subject_name: Tandutinib

object_name: acute myeloid leukemia


subject: CHEBI:90237

object_name: Myelodysplasia


subject: CHEBI:90237

object_name: Adult Myelodysplastic Syndrome


subject: CHEBI:90237

object_name: childhood myelodysplastic syndrome


subject: CHEBI:90237

object_name: Myelodysplastic Syndrome, CTCAE


subject: UMLS:C1384662


subject: UMLS:C1384662


subject: UMLS:C1384662


subject: UMLS:C1384662


subject: UMLS:C1384662


subject: CHEBI:6121

subject_name: Ketamine

object_name: retinal disease


subject: CHEBI:6121

object_name: Retinopathy


subject: CHEBI:6121

object_name: Retinopathy, CTCAE


subject: CHEBI:9130

subject_name: Sevoflurane


subject: CHEBI:9130


subject: CHEBI:9130


subject: CHEBI:44915

subject_name: Propofol


subject: CHEBI:44915


subject: CHEBI:44915


subject: UMLS:C5783941

subject_name: P2Y12 Inhibitor

object_name: acute coronary syndrome


subject: UNII:C82R061MZ5

object_name: atherosclerosis


subject: UNII:8JYO8VTR11


subject: UNII:2P471X1Z11

subject_name: Omalizumab

object_name: acute tubulointerstitial nephritis


subject: UMLS:C0910794


subject: CHEBI:8382

subject_name: Prednisone


subject: CHEBI:180905

subject_name: Nicardipine

object_name: Cerebral Vasospasm